bromocriptine has been researched along with levodopa in 622 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 383 (61.58) | 18.7374 |
| 1990's | 140 (22.51) | 18.2507 |
| 2000's | 77 (12.38) | 29.6817 |
| 2010's | 19 (3.05) | 24.3611 |
| 2020's | 3 (0.48) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Quik, M; Sourkes, TL | 1 |
| Winkelman, AC | 1 |
| Goldfine, ID | 1 |
| Frantz, AG; Kleinberg, DL | 1 |
| Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S | 1 |
| Hungerbühler, JP; Regli, F | 1 |
| Rinne, UK | 9 |
| Ringwald, E | 1 |
| Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN | 2 |
| Przuntek, H | 1 |
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Heuson, JC; Rozencweig, M | 1 |
| Debono, AG; Donaldson, I; Marsden, CD; Parkes, JD | 1 |
| Debono, AG; Marsden, CD; Parkes, JD | 2 |
| Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P | 1 |
| Lipper, S | 1 |
| Calne, DB; Neophytides, A; Nutt, JG; Plotkin, C; Teychenne, PF; Williams, AC | 1 |
| Glaubman, H; Rabey, JM; Streifler, M; Vardi, J | 1 |
| Lees, AJ; Shaw, KM; Stern, GM | 1 |
| Lörincz, P; Ludin, HP; Ringwald, E | 1 |
| Cowden, EA; Doyle, D; Macpherson, P; Ratcliffe, JG; Teasdale, GM; Thomson, JA | 1 |
| Bannister, R | 1 |
| Ahmann, PA; Ali, FM; Camp, VM; Caplan, DB; Faraj, BA; Newman, SL | 1 |
| Kanatsuka, A; Kumagai, A; Makino, H; Matsushima, Y; Osegawa, M; Yamamoto, M | 1 |
| Cowden, EA; Dobbie, JW; Kennedy, AC; Ratcliffe, JG; Ratcliffe, WA | 1 |
| Hicks, PB; Samorajski, T; Smith, RC; Strong, JR | 1 |
| Werner, S | 1 |
| Avidan, S; Ayalon, D; Cordova, T; Harell, A; Jedwab, G; Persitz, E; Ravid, R | 1 |
| Chamuleau, RA | 1 |
| Cocchi, D; Locatelli, V; Müller, EE; Panerai, AE; Salerno, F | 1 |
| Lander, CM; Lees, A; Stern, G | 1 |
| Chiodini, PG; Cocchi, D; Lacatelli, V; Liuzzi, A; Mantegazza, P; Müller, EE; Oppizzi, G; Panerai, AE; Silvestrini, F | 1 |
| Caine, E; Carter, AC; Ebert, M; Kartzinel, R | 1 |
| Caraceni, T; Cocchi, D; Müller, EE; Panerai, AE; Parati, EA | 1 |
| Battista, AF; Goldstein, M; Miyamoto, T | 1 |
| Calne, DB; Kartzinel, R; Shoulson, I | 2 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Battista, AF; Goldstein, M; Lew, JY; Lieberman, A; Matsumoto, Y | 1 |
| Hill, JW | 1 |
| Agnati, LF; Benfenati, F; Capelli, M; Cortelli, P; D'Alessandro, R; Galassi, E | 1 |
| Hiestand, PC | 1 |
| Dent, R; Guyda, H; Tolis, G | 1 |
| Caine, ED; Davis, GC; Ebert, MH; Kopin, IJ; Markey, SP; Reichert, CM; Williams, AC | 1 |
| Castegnaro, E; Pontiroli, AE; Pozza, G; Vettaro, MP; Viberti, GC | 1 |
| Durand, JP; Gautier, JC | 1 |
| Godwin-Austen, RB; Smith, NJ | 1 |
| Gron, U | 1 |
| Hansen, E; Kristensen, O | 1 |
| Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A | 1 |
| Frantz, AG | 1 |
| Jansen, EN | 1 |
| Agnoli, A; Casacchia, M; Ruggieri, S | 1 |
| Pearce, I; Pearce, JM | 1 |
| Bateman, DN; Coxon, A; Legg, NJ; Reid, JL | 1 |
| Lance, JW; Mackenzie, RA | 2 |
| Agid, Y; Barroche, G; Bonnet, AM; Javoy-Agid, F; Kato, G; Lhermitte, F; Pollak, P; Signoret, JL | 1 |
| Parkes, D | 1 |
| Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E | 1 |
| Abu-fadil, S; Lachelin, GC; Yen, SS | 1 |
| Carmina, E; Jannì, A; Lanzara, P; Lo Coco, R; Longo, RA | 1 |
| Cei, S; Cosimato, F; Lombardi, G; Minozzi, M; Panza, N | 1 |
| Marx, JL | 1 |
| Clanet, M; David, J; Guiraud, B; Montastruc, JL; Rascol, A | 1 |
| Albizzati, MG; Frattola, L; Scarlato, G; Trabucchi, M | 1 |
| Barreca, T; Masturzo, P; Rolandi, E | 1 |
| List, SJ; Seeman, P | 1 |
| Bender, DA; Earl, CJ; Lees, AJ | 1 |
| Brandi, AM; Bression, D; Cesselin, F; Mauborgne, A; Nousbaum, A; Peillon, F; Zygelman, N | 1 |
| Glaubman, H; Rabey, J; Streifler, M; Vardi, J | 1 |
| Allelov, M; Flechter, S; Hertzberg, M; Oberman, Z; Rabey, JM; Streifler, M; Vardi, J | 1 |
| Lefebvre, J; Linquette, M; Loeuille, GA; Steinling, M | 1 |
| Kellams, JJ; Lemberger, L; Rowe, H; Small, JG | 1 |
| Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Snider, SR | 1 |
| Aloorkar, SD; Pandya, SK; Sheth, AR; Vaidya, RA | 1 |
| Ben-David, M; Polishuk, WZ; Spitz, IM; Yarkoni, S | 1 |
| Lachelin, GC; Leblanc, H; Yen, SS | 1 |
| Fahn, S; Hutt, CS; Snider, SR | 1 |
| Jotkowitz, S | 1 |
| Delitala, G | 1 |
| Caraceni, TA; Celano, I; Girotti, F; Parati, E | 1 |
| Banovac, K; Petek, M; Sekso, M; Solter, M; Vizner, B | 1 |
| Kanezuka, H; Makino, E; Matsushima, Y; Osegawa, M; Yamamoto, A | 1 |
| Gragnoli, G; Martinelli, G; Pallassini, A; Signorini, AM; Tanganelli, I | 1 |
| Gershon, S; Shopsin, B | 1 |
| Barbeau, A; Bélanger, F; Butterworth, RF | 1 |
| Johnels, B; Steg, G; Ungerstedt, U | 1 |
| Bédard, P; Marsden, CD; Parkes, JD | 1 |
| Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF | 1 |
| Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM | 1 |
| Jacobi, JM; Lloyd, HM | 1 |
| Brandi, A; Cesselin, F; Mauborgne, A; Peillon, F; Zygelman, N | 1 |
| Marttila, R; Rinne, UK | 1 |
| Lees, A; Stern, G | 1 |
| Barreca, T; Gallamini, A; Murialdo, G; Nizzo, MC; Polleri, A | 1 |
| Yahr, MD | 1 |
| Gilligan, B; Stark, R; Wodak, J | 1 |
| Robyn, C | 1 |
| Gerlach, J | 1 |
| Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
| El'tsina, NV | 1 |
| Perez-Lopez, FR | 1 |
| Pohto, P | 1 |
| Ward, HW | 1 |
| Bartolini, A; Mantovani, P; Pepeu, G | 1 |
| Bunney, WE | 1 |
| Rabey, JM; Streifler, M; Vardy, J | 1 |
| Marttila, R; Rinne, UK; Sonninen, V | 1 |
| Calne, DB; Pfeiffer, RF; Teychenne, PF | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Aono, T; Kohno, M; Kurachi, K; Shioji, T; Ueda, G | 1 |
| Calne, DB; Kartznel, R | 1 |
| McLellan, DL | 1 |
| Estey, E; Goldstein, M; Kupersmith, M; Lieberman, A | 1 |
| Alagna, S; Delitala, G; Devilla, L; Lotti, G; Masala, A | 1 |
| Dickey, RP; Stone, SC | 1 |
| Bassendine, MF; Calne, DB; Claveria, LE; Petrie, A; Teychenne, PF | 1 |
| Camanni, F; Isaia, GC; Massara, F; Molinatti, GM | 1 |
| Alagna, S; Delitala, G; Devilla, L; Masala, A | 1 |
| Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
| Reid, WG | 1 |
| Kamal, TJ; Molitch, ME | 1 |
| Alves, RS; Barbosa, ER; Scaff, M | 1 |
| Lieberman, A | 2 |
| Mizuno, Y | 1 |
| Goto, I; Iwata, M; Kanazawa, I; Kowa, H; Mannen, T; Mizuno, Y; Nakanishi, T; Nishitani, H; Ogawa, N; Takahashi, A | 6 |
| Kraus, PH; Letzel, H; Przuntek, H; Schwarzmann, D; Welzel, D | 1 |
| Blümner, E; Danielczyk, W; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Schwarzmann, D; Welzel, D; Wolf, H | 1 |
| Andersson, U; Aquilonius, SM; Freccero-Rosman, K; Lindvall, O; Nylander, B; Odin, P | 1 |
| Albani, F; Baruzzi, A; Contin, M; Martinelli, P; Riva, R | 1 |
| Levivier, M; Przedborski, S | 1 |
| Laihinen, A; Rinne, UK; Suchy, I | 1 |
| Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P | 1 |
| Haas, JA; Jansen, EN; Lakke, JP; Staal-Schreinemachers, A; van der Sande, JJ | 1 |
| Durrieu, G; LLau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
| Graff, E; Korczyn, AD; Rabey, JM; Shabtai, H; Vered, Y | 1 |
| Suitsu, N | 1 |
| Cooper, JA; Jordan, N; Sagar, HJ | 1 |
| Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA | 1 |
| Allain, H; Bentue-Ferrer, D; Decombe, R; Lemaitre, MH; Martinet, JP; Milon, D | 1 |
| Morgan, MY | 1 |
| Fujishima, M; Ikenoue, H; Kuroda, T; Okamura, K; Sato, K; Tokuyama, T; Yoshinari, M | 1 |
| Chokroverty, S; Hening, WA; Walters, AS | 1 |
| Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D | 1 |
| Allain, H; Bentue-Ferrer, D; Brunet-Bourgin, F; Chaumet-Riffaud, P; Decombe, R; Gandon, JM; Goulley, F; Le Coz, F; Loria, Y; Reymann, JM | 1 |
| Graff, E; Harsat, A; Rabey, JM; Schwartz, M; Vered, Y | 1 |
| Nakashima, K; Takahashi, K | 1 |
| Chariá, P; Díaz, F; Liberman, C | 1 |
| Onodera, K; Shinoda, H | 1 |
| Jacobs, MB; Varon, J | 1 |
| Goto, I; Harada, M; Kira, J; Shida, N; Yamaguchi, Y | 1 |
| Eriksson, T; Oberg, B; Pedersen, SW | 1 |
| Davis, A; Jenner, P; Marsden, CD | 1 |
| Haba, K; Mizukawa, K; Ogawa, N; Sato, H | 1 |
| Bédard, PJ; Di Paolo, T; Gagnon, C | 1 |
| Kempi, V; von Scheele, C | 1 |
| Kleedorfer, B; Poewe, W; Schelosky, L | 1 |
| Durrieu, G; Montastruc, JL; Rascol, A; Senard, JM; Tran, MA | 1 |
| MacMahon, DG; Marshall, T; Overstall, PW | 1 |
| Edwards, RL; Oliver, WA; Todman, DH | 1 |
| Montastruc, JL; Rascol, A; Rascol, O | 3 |
| Cowan, A | 1 |
| Arvat, E; Bellone, J; Camanni, F; Ghigo, E; Imperiale, E; Mazza, E; Procopio, M | 1 |
| Olsson, JE | 1 |
| Becker, AL; Bilchik, TR; Blumenfeld, A; Fourie, PB; Fritz, VU; Ming, A; Reef, HE; Saling, M; Temlett, JA | 1 |
| Bédard, PJ; Di Paolo, T; Rouillard, C | 1 |
| Bakheit, AM; Henderson, LM; Moore, AP; Simpson, JA; Thomas, M | 1 |
| Dufresne, JJ | 1 |
| Bar, M; Graff, E; Isakov, M; Oberman, Z; Rabey, JM; Scharf, M | 1 |
| Bédard, P; Boucher, R; Daigle, M; Di Paolo, T | 1 |
| Albani, G; Amabile, G; Fattapposta, F; Morocutti, C; Pozzessere, G; Rizzo, PA; Sanarelli, L | 1 |
| Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W | 1 |
| Pidgeon, JF; Wolf, MA | 1 |
| Bartholomew, M; Boucher, AE; Demers, LM; Harvey, HA; Lipton, A; Manni, A; Simmonds, MA | 1 |
| Bar, M; Graff, E; Isakov, A; Oberman, Z; Rabey, JM; Scharf, M | 1 |
| Broe, GA; Genge, S; Hely, MA; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM | 2 |
| Selby, G | 1 |
| Glatt, S; Hassanein, R; Koller, WC; Vetere-Overfield, B | 1 |
| Benabid, AL; Champay, AS; Hommel, M; Perret, JE; Pollak, P | 1 |
| Ackermann, H; Oertel, WH; Ziegler, W | 1 |
| Villares, JC | 1 |
| Calne, D; Hertzman, C; Snow, B; Wiens, M | 1 |
| Beart, PM; Cook, CJ; Hashizume, M; Jackson, DM; Tabar, J | 1 |
| Goldberg, LI; Rajfer, SI | 1 |
| Becker, RE; Blitzer, RD | 1 |
| Casey, DE | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
| Dichgans, J; Scholz, E | 1 |
| Harvey, NS | 1 |
| Minagawa, F; Nakabayashi, H; Takeda, R | 1 |
| Aono, T; Hidaka, H; Iwase, K; Masunaga, R; Nagasaka, A; Nakagawa, H; Nakai, A; Ohyama, T | 1 |
| Jenner, P; Marsden, CD | 1 |
| Huber, M | 1 |
| Boyce, S; Jenner, P; Marsden, CD | 1 |
| Cummings, JL; Friedenberg, DL | 1 |
| Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA | 1 |
| Facchinetti, F; Genazzani, AR; Golinelli, S; Oltramari, P; Petraglia, F; Santoro, V; Volpe, A | 1 |
| Pugsley, TA; Stewart, SF | 1 |
| Berlan, M; Boneu, B; Caranobe, C; Lafontan, M; Montastruc, JL; Rascol, A; Villeneuve, A | 1 |
| Cella, SG; Lampis, A; Locatelli, V; Loche, S; Müller, EE; Pintor, C | 1 |
| Herskovits, E; Leston, J; Yorio, A | 1 |
| Hassing, JM; Huseman, CA; Sibilia, MG | 1 |
| Laihinen, A; Rinne, UK | 1 |
| LeWitt, PA | 1 |
| Mondal, BK; Mondal, KN | 1 |
| Birkmayer, JD; Birkmayer, W | 1 |
| Jansen, EN; Meerwaldt, JD | 1 |
| Aminoff, MJ | 1 |
| Huang, KE; McDonald, JV; Muechler, EK; Tang, L | 1 |
| Perić, LA; Prelević, GM; Würzburger, MI | 1 |
| Dash, RJ; Rao, NS; Sialy, R; Sriprakash, ML | 1 |
| Fujita, M; Shimizu, T | 1 |
| Dubuis, R | 1 |
| Birkmayer, W | 1 |
| Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S | 1 |
| Calne, DB; Rinne, UK | 1 |
| Holland, OB; Kennedy, B; Lake, CR; Murphy, D; Ziegler, MG | 1 |
| Boyadjieva, M; Ovtcharov, R; Zaharieva, B | 1 |
| Hashimoto, T; Koda, H; Kuriyama, K | 1 |
| Hanew, K; Mizuno, Y; Sakuma, H; Takase, S; Teramura, K | 1 |
| Bouchard, S; Gawel, MJ; King, DB; Libman, I; McLean, DR; Paulseth, R; Raphy, B; Riopelle, RJ | 1 |
| Wallis, WE | 2 |
| Bouchard, S; Gawel, MJ; Libman, I; Riopelle, RJ | 1 |
| Allain, H; Bentué-Ferrer, D; Reymann, JM; Sabouraud, O; Van den Driessche, J | 1 |
| Perquin, WV; Van Leeuwen, RB | 1 |
| Wermuth, L | 1 |
| Larsen, JP; Nessler, EG; Strandjord, R | 1 |
| Berman, ML; Tennant, F | 1 |
| Lyman, CP; O'Brien, RC | 1 |
| Bédard, PJ; Dipaolo, T; Falardeau, P; Rouillard, C | 1 |
| Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y | 1 |
| Geber, J; Gjuris, V; Krizanac, S; Mise, S; Petek, M; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M; Udovicić, I | 1 |
| Gollomp, SM; Hurtig, HI; Stern, MB; Vernon, GM | 1 |
| Bédard, PJ; Boucher, R; Di Paolo, T; Falardeau, P | 1 |
| Williams, A | 1 |
| Robertson, GS; Robertson, HA | 1 |
| Agniel, A; Celsis, P; Demonet, JF; Doyon, B; Marc-Vergnes, JP; Montastruc, JL; Puel, M; Rascol, A | 1 |
| Kato, K; Seki, K; Shima, K | 1 |
| Akpinar, S | 1 |
| Bouchard, S; Gawel, M; Libman, I; Riopelle, R | 1 |
| Lindvall, B; Olsson, JE | 1 |
| Lakke, JP; Staal-Schreinemachers, AL | 1 |
| Aso, K; Furune, S; Negoro, T; Nomura, K; Takahashi, I; Watanabe, K; Yamamoto, N | 1 |
| Sandyk, R | 2 |
| Gibson, JM; Kennard, C; Pimlott, R | 1 |
| Riopelle, RJ | 1 |
| Bouchard, S | 1 |
| Lazarus, A | 1 |
| Kadykov, AS; Pivovarova, VM; Shvedkov, VV; Stoliarova, LG | 1 |
| Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF | 1 |
| Muenter, MD | 2 |
| Klawans, HL; Paleologos, N | 1 |
| Lakke, JP; Staal-Schreinemachers, AL; Wesseling, H | 1 |
| Barkemeyer, CA; Hawkins, MF; Tulley, RT | 1 |
| Palmieri, V; Tardi, S; Ventrella, F | 1 |
| Draper, IT | 1 |
| Wilson, JA | 1 |
| Calne, DB; Glover, R; Lau, E; Schulzer, M; Waterman, K | 1 |
| Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD | 1 |
| Goh, M; Hanew, K; Sasaki, A; Sato, S; Yoshinaga, K | 1 |
| Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 2 |
| Cvitanović, B; Geber, J; Gjuris, V; Ivanović, D; Mise, S; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M | 1 |
| Johnels, B | 1 |
| van der Drift, JH | 1 |
| de Pedro, J; Rosenqvist, U | 1 |
| Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
| Jonsson, G; Mefford, I; Schultz, W; Studer, A; Sundström, E | 1 |
| Jackson, DM; Jenkins, OF | 1 |
| Jankovic, J | 1 |
| Hardie, RJ; Lees, AJ; Stern, GM | 1 |
| Goldstein, M; Lieberman, AN | 1 |
| Bruggendieck, B; Campino, C; Generini, G; Michelsen, H; Piraino, P; Pumarino, H | 1 |
| Feldman, RG; Lannon, MC | 1 |
| Huseman, CA | 1 |
| Boiadzhieva, N; Ovcharov, R; Zakharieva, B | 1 |
| Wirz, D | 1 |
| Hirooka, M; Itoh, M; Nagasaka, A; Nakagawa, H; Nakagawa, K; Nakai, A; Nihei, N; Ohyama, T; Sugiura, T; Yabe, Y | 1 |
| Hietala, J; Koulu, M; Scheinin, M; Syvälahti, E | 1 |
| Bowser, EN; Hargis, GK; Kukreja, SC; Sethi, R; Williams, GA | 1 |
| Agid, Y; Dubois, B | 1 |
| Elton, RL; Hoehn, MM | 1 |
| Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G | 1 |
| Delgado, MR; Grimes, JD | 1 |
| Kapfhammer, HP; Rüther, E | 1 |
| Hoehn, MM | 2 |
| Ando, K; Mano, Y; Satoyoshi, E; Sunohara, N | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Baas, H; Fischer, PA; Japp, G; Schneider, E | 2 |
| Indo, T | 1 |
| Su, YH | 1 |
| Aleksić, J; Geber, J; Gjuris, V; Ivanović, D; Marović, A; Reić, P; Sikirić, P; Suchanek, E | 1 |
| Grau-Veciana, JM; Peiró Grasa, A | 1 |
| Morris, JG | 3 |
| Schott, GD | 1 |
| Hershey, LA | 1 |
| Luquin, MR; Martínez Lage, JM; Obeso, JA | 1 |
| Bamji, AN; Calne, DB; Greenacre, JK; Leigh, PN; Teychenne, PF | 1 |
| Assies, J; Schellekens, AP; Touber, JL | 1 |
| Burton, K; Calne, DB | 1 |
| Calne, DB; Plotkin, CN; Rosin, AJ; Teychenne, PF | 1 |
| Goldfine, ID; Vigneri, R | 1 |
| Frohman, LA; Maeda, K | 1 |
| Lees, AJ; Stern, GM | 2 |
| Misra, P | 1 |
| Hallett, M | 1 |
| Andreeva, OG; Korovin, KF; Ostroumova, MN; Schelkunov, EL | 1 |
| Ross, ED; Stewart, RM | 1 |
| Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG | 1 |
| Larsen, TA; Teräväinen, H | 1 |
| Weiner, M | 1 |
| Hoyumpa, AM; Schenker, S | 1 |
| Altilia, F; Amadio, R; Cipollini, F | 1 |
| Ishibashi, M; Yamaji, T | 1 |
| West, AP | 1 |
| Marchesini, G; Pisi, E | 1 |
| Goldberg, LI | 1 |
| Kurako, IuL; Volianskiĭ, VE | 1 |
| Jellinger, K | 1 |
| Fischer, PA; Schneider, E | 1 |
| Jörg, J | 1 |
| Biesemeyer, H; Ludin, HP; Ringwald, E | 1 |
| Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
| Laakso, K; Laihinen, A; Lönnberg, P; Rinne, JK; Rinne, JO; Rinne, UK | 1 |
| Globus, M; Melamed, E | 1 |
| Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD | 1 |
| Crossley, IR; Williams, R | 1 |
| Fischer, PA; Majer, M; Przuntek, H; Welzel, D | 1 |
| Barontini, M; Bazán, MC; Bergadá, C; Domené, H; Heinrich, JJ | 1 |
| Avidan, S; Ayalon, D; Caufriez, A; Eckstein, N; Eshel, A; L'Hermite, M; Spitz, I; Zylber-Haran, E | 1 |
| Hassing, JM; Huseman, CA | 1 |
| Bihari, K; Csanda, E; Köves, A; Mogyorós, I; Takáts, A; Tárczy, M | 1 |
| Koulu, M; Lammintausta, R | 1 |
| Alonso, RJ; Covington, TR; Mancall, EL | 1 |
| Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
| Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
| Armstrong, D; Courtney, CL; Palfai, T | 1 |
| Ambrosoli, C; Armocida, G; Finavera, L; Majeron, MA; Quisi, Q | 1 |
| Destée, A; Fossati, P; Petit, H; Warot, P | 1 |
| Bouchard, S; Grimes, JD; King, DB; Kofman, OS; Molina-Negro, P; Wilson, AF | 1 |
| Ackman, D; Etienne, P; Kiely, ME; Lal, S; Thavundayil, JX | 1 |
| Calne, DB; Larsen, TA; LeWitt, P; Newman, R | 1 |
| Fischer, PA; Hubener, K; Schneider, E | 2 |
| Schiffter, R; Vogel, HP | 1 |
| Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G | 1 |
| Lipcsey, A; Peres, A | 1 |
| Goldstein, M; Gopinathan, G; Hassouri, H; Lieberman, AN; Neophytides, A | 1 |
| Calne, DB; Newman, RP | 1 |
| Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N | 1 |
| Bear, G; Casson, I; Durso, R; Foo, SH; Goldstein, M; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A | 1 |
| Anile, C; Barbarino, A; De Marinis, L; Maira, G | 1 |
| Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
| Allain, H; Bentue-Ferrer, D; Pape, D; Reymann, JM; Sabouraud, O; van den Driessche, J | 1 |
| Brismar, K | 1 |
| Chang, CC; Chang, TC; Chen, FW; Huang, TS | 1 |
| Calne, DB; Eisler, T; Kaiser, DL; MacLeod, RM; Thorner, MO | 1 |
| Bannet, J; Belmaker, RH; Globus, M; Lerer, B | 1 |
| Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R | 1 |
| Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
| Delwaide, PJ; Schoenen, J | 1 |
| McDevitt, JT; Setler, PE | 1 |
| Hammond, CB; Vaughn, TC | 1 |
| Agnati, LF; Fuxe, K | 1 |
| Calne, DB; Teräväinen, H | 1 |
| Calne, DB; Le Witt, PA | 1 |
| Glantz, R; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| Gnatyshak, AI | 1 |
| Adam, WR; Campbell, DJ; Funder, JW; Mendelsohn, FA | 1 |
| Goetz, CG; Nausieda, PA; Tanner, CM | 1 |
| Haas, JA; Lakke, JP | 1 |
| Iimura, O; Nakagawa, M; Shimamoto, K | 1 |
| Bauman, JE; Masters, WH; Schwartz, MF | 1 |
| Klawans, HL | 1 |
| Gauthier, G; Martins da Silva, A | 1 |
| Kaplan, LR; Klawans, HL; Nausieda, PA; Weber, S; Weiner, WJ | 1 |
| Cunningham, JR; Duchesneau, PM; Gidwani, GP; Gupta, MS; Schumacher, OP | 1 |
| Agid, Y; Illas, A; Lhermitte, F; Quinn, N | 1 |
| Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B | 1 |
| Lieberman, AN; Plasse, HM | 1 |
| Ulm, G | 1 |
| Grimes, JD; Hassan, MN | 1 |
| Agid, Y; Lhermitte, F; Quinn, N | 1 |
| Stewart, RM | 1 |
| Fang, VS | 1 |
| Malarkey, WB; Tallo, D | 1 |
| Bøttcher, J; Grøn, U | 1 |
| Angelini, L; Broggi, G; Mainini, P; Moretti, G; Nardocci, N | 1 |
| Caraceni, T; Giovannini, P; Girotti, F; Parati, E; Pederzoli, M; Scigliano, G | 1 |
| Danielczyk, W | 1 |
| Alberetto, M; De Castro e Silva, E; De Pasqua, A; Girardi, AM; Pellicciotta, G; Pontiroli, AE; Pozza, G | 1 |
| Casson, I; Durso, R; Foo, SH; Goldstein, M; Gopinathan, G; Khayali, M; Kupersmith, M; Lieberman, AN; Neophytides, A; Tartaro, T | 1 |
| Barrett, RE; Côté, LJ; Fahn, S; Snider, SR | 1 |
| Godwin-Austen, RB | 1 |
| Lander, CM; Lees, AJ; Shaw, KM; Stern, GM | 1 |
| Duvoisin, RC; Mendoza, MM; Yahr, MD | 1 |
| Bédard, P; Debono, AG; Dorow, R; Horowski, R; Jenner, P; Keenan, J; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J; Schachter, M; Smith, B | 1 |
| Biller, B; Feldman, ZT; Gagel, RF; Graze, K; Kapcala, LP; Reichlin, S; Spiler, IJ; Tashjian, AH | 1 |
| Bertha, G; Lechner, H; Ott, E | 1 |
| Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP | 1 |
| Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW | 1 |
| Eadie, MJ | 1 |
| Ludin, HP | 1 |
| Clinnick, S; Fonda, D; Schwarz, J | 1 |
| Janjua, R; Roos, RA; van Kempen, GM | 1 |
| Modigliani, E | 1 |
| Danysz, W; Quack, G; Rogoz, Z; Skuza, G | 1 |
| Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G | 1 |
| Mark, MH; Sage, JI | 1 |
| Asanuma, M; Kawai, M; Kohno, M; Masumizu, T; Mori, A; Ogawa, N; Tanaka, K | 1 |
| Ogawa, N | 1 |
| Goto, I; Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N | 3 |
| Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O | 1 |
| Eberli, F; Greminger, P; Schmid, PA; Speich, R; Suter, T | 1 |
| Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G | 1 |
| Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM | 1 |
| Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM | 1 |
| Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
| Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK | 1 |
| Yanagisawa, N | 2 |
| Dichgans, J; Klockgether, T | 1 |
| Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR | 1 |
| Lauterbach, EC | 1 |
| Cooper, JA; Sagar, HJ; Sullivan, EV | 1 |
| Comella, CL; Ristanovic, RK; Tanner, CM | 1 |
| Klockgether, T; Löschmann, PA; Schugens, MM | 1 |
| Rumbach, L; Tranchant, C; Viel, JF; Warter, JM | 1 |
| Factor, SA; Weiner, WJ | 1 |
| Kuno, S | 2 |
| Chanter, DO | 1 |
| Kornhuber, J; Weller, M | 1 |
| Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ | 1 |
| Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G | 1 |
| Hadjiconstantinou, M; Hubble, JP; Neff, NH; Sylvia, CP; Wemlinger, TA | 1 |
| Abercrombie, ED; DeBoer, P; Heeringa, M; Westerink, BH | 1 |
| Amiel, C; Comoy, E; Couette, S; Friedlander, G; Garcia-Ocaña, A; Perrichot, R | 1 |
| Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M | 1 |
| Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I | 1 |
| Lees, AJ | 1 |
| Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G | 1 |
| Akiyama, K; Ishihara, T; Kashihara, K; Shiro, Y; Shohmori, T | 1 |
| Ahlskog, JE | 1 |
| Kishore, A; Snow, BJ | 1 |
| Benabid, AL; Benazzouz, A; Hoffmann, D; Limousin, P; Perret, JE; Pollak, P | 1 |
| Akiyama, K; Ishihara, T; Kashihara, K; Kuroda, S; Morimasa, T; Shomori, T | 1 |
| Akiguchi, I; Fukuyama, H; Imai, T; Kawamura, J; Kimura, J | 1 |
| Dierks, T; Grosse, H; Kuhn, W; Müller, T; Rommelspacher, H | 1 |
| Adena, MA; Broe, GA; Hely, MA; Morris, JG; O'Sullivan, DJ; Reid, WG; Williamson, PM | 1 |
| Blümner, E; Danielczyk, W; Gerlach, M; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Uberla, K; Welzel, D | 1 |
| Fukuda, T; Tanaka, J; Watabe, K | 1 |
| de Saint-Martin, A; Hirsch, E; Marescaux, C; Picard, F; Salmon, E | 1 |
| Montastruc, JL; Rascol, O; Senard, JM | 2 |
| del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A | 1 |
| Berlot, G; Cociancich, N; Gullo, A; Tomasini, A; Viviani, M | 1 |
| Burguera, JA; Chacón, J; Forcadell, F; Giménez-Roldán, S; Liaño, H; Tolosa, E | 1 |
| Fukuzaki, K; Kitahara, K; Kohno, Y; Koja, T | 1 |
| Mizuno, Y; Yanagisawa, N | 1 |
| Agid, Y; Destée, A; Durif, F; Montastruc, JL; Pollak, P | 1 |
| Giménez-Roldán, S; Mateo, D | 1 |
| de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R | 1 |
| Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N | 1 |
| McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF | 1 |
| Araki, T; Itoyama, Y; Kobayashi, T; Ohta, T; Oshima, Y; Takeshita, M | 1 |
| Baudewig, J; Bruns, D; Paulus, W; Tergau, F; Ziemann, U | 1 |
| Marsden, CD | 1 |
| Banerji, T; Jenner, P; Marsden, CD; Pearce, RK | 1 |
| Abrams, KR | 1 |
| Ben-Shlomo, Y; Churchyard, A; Head, J; Hurwitz, B; Lees, AJ; Ockelford, J; Overstall, P | 1 |
| Brotchie, JM; Crossman, AR; Henry, B | 2 |
| Amano, K; Takakura, K | 1 |
| Haida, M; Kozuma, R; Shinohara, Y; Takagi, S; Takahashi, W; Yoshii, F | 1 |
| Adair, JC; Davis, LE | 1 |
| Brunt, ER; Korczyn, AD; Larsen, JP; Nagy, Z; Poewe, WH; Ruggieri, S | 1 |
| Sunohara, N | 1 |
| Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M | 1 |
| Weiner, WJ | 1 |
| Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S | 1 |
| Finken, MJ; Ramaker, C; van de Beek, WJ; van Hilten, BJ | 1 |
| Clarke C, E; Speller J, M | 1 |
| Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ | 1 |
| Clarke, CE; Speller, JM | 1 |
| Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW | 1 |
| Hirschelmann, R; Thong, NT | 1 |
| Clarke, CE; Deane, KH | 2 |
| Ramaker, C; van Hilten, JJ | 1 |
| Clarke C, E; Clarke J, A; Speller J, M | 1 |
| Asanuma, M; Ogawa, N; Tanaka, K | 1 |
| Milkov, V; Miteva, K; Pironcheva, G; Russev, G; Zlatarev, S | 1 |
| Hasegawa, K | 1 |
| Fukuzaki, K; Kamenosono, T; Kitazumi, K; Nagata, R | 1 |
| Haapaniemi, TH; Kallio, MA; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U | 1 |
| Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
| Clarke, CE; Deane, KD | 1 |
| Haapaniemi, TH; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U | 1 |
| Chew, EL; Ong, KC; Ong, YY | 1 |
| Brefel-Courbon, C; Desboeuf, K; Lapeyre-Mestre, M; Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Susman, VL | 1 |
| Bamias, C; Hardy, P; Pocock, S; Warner, J; White, IR | 1 |
| Andersson, M; Cenci, MA; Lundblad, M; Westin, JE | 1 |
| Ben-Shlomo, Y; Head, J; Katzenschlager, R; Lees, AJ | 1 |
| Hillman, R; Parvez, F; Pendleton, RG; Sayed, M | 1 |
| Andersson, M; Cenci, MA; Kirik, D; Lundblad, M; Wierup, N; Winkler, C | 1 |
| Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F | 1 |
| Keens, J; Schrag, A; Warner, J | 1 |
| Bittkau, S; Bliesath, H; Büttner, U; Fuchs, G; Glass, J; Haller, H; Klockgether, T; Kraus, P; Lachenmayer, L; Müller, D; Müller, T; Przuntek, H; Rathay, B; Sgonina, J; Steinijans, V; Teshmar, E; Ulm, G; Volc, D | 1 |
| Hilten, JJ; Ramaker, C | 1 |
| Bar-Gad, I; Bergman, H; Goldberg, JA; Heimer, G | 1 |
| Hauser, RA; Holford, NH | 1 |
| Kondo, T | 1 |
| Cannizzaro, C; Jenner, P; Pearce, RK; Rose, S; Tel, BC; Zeng, BY | 1 |
| Reingardiene, D | 1 |
| Cho, IS; Ha, JH; Im, JH; Lee, MC | 1 |
| Quinn, NP | 1 |
| Debette, S; Kozlowski, O; Rousseaux, M; Steinling, M | 1 |
| Lai, BC; Marion, S; Schulzer, M; Teschke, K; Tsui, JK | 1 |
| Beier, KM; Berger, Ch; Mehrhoff, FW; Meinck, HM | 1 |
| Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD | 1 |
| Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
| Okamoto, K; Tanaka, M | 1 |
| Allain, H; Colin, F; Flet, L; Polard, E; Trioux, E | 1 |
| Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
| Gispen-de Wied, CC; Kahn, RS; Kemner, C; Oranje, B; Verbaten, MN; Westenberg, HG | 2 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Clarke, CE; Deane, KH; Spieker, S | 1 |
| Hely, MA; Morris, JG; Reid, WG; Trafficante, R | 1 |
| Hoffmann, A; Klotz, P; Kraus, PH; Lewe, J; Przuntek, H | 1 |
| Jost, WH | 1 |
| Mitsumoto, Y; Mori, A; Moriizumi, T; Nakai, M; Ohashi, S | 1 |
| Chen, WH; Liu, JS; Lu, YC; Lui, CC | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Elovic, EP; Napolitano, E; Qureshi, AI | 1 |
| Azouvi, P; Ben Smaïl, D; Régnault, J; Rouy-Thenaisy, K; Samuel, C | 1 |
| Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G | 1 |
| Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I | 1 |
| Turnbull, GI | 1 |
| Cenci, MA; Lindgren, HS; Lundblad, M; Ohlin, KE; Rylander, D | 1 |
| Colau, JC; Ha, DE; Legendre, G | 1 |
| Lindh, J | 1 |
| Ives, NJ; Ramaker, CC; Stowe, R; van Hilten, JJ | 2 |
| Ben-Shlomo, Y; Evans, A; Head, J; Katzenschlager, R; Lees, AJ; Schrag, A | 1 |
| Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S | 1 |
| Marín, E; Uribe, M | 1 |
| Montgomery, EB | 1 |
| Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
| Awa, Y; Hattori, T; Higuchi, Y; Ichikawa, T; Ito, T; Kobayashi, M; Kuwabara, S; Sakakibara, R; Uchiyama, T; Yamaguchi, C; Yamamoto, T; Yamanishi, T; Yanagisawa, M; Yano, M | 1 |
| Aubut, JA; Bayley, M; Foley, N; Marshall, S; Megyesi, J; Meyer, MJ; Meythaler, J; Murie-Fernandez, M; Salter, K; Teasell, R | 1 |
| Bormans, G; Bosier, B; Casteels, C; Lambert, DM; Van Laere, K; Vanbilloen, B; Vercammen, D | 1 |
| Dunnett, SB; Lane, EL | 1 |
| Schneemilch, C | 1 |
| Halliday, GM; Hely, MA; Loy, C; Morris, JG; Reid, WG | 1 |
| Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E | 1 |
| Amato, L; Davoli, M; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P | 1 |
| Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H | 1 |
| Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
| Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T | 1 |
| Als-Nielsen, B; Gluud, C; Gluud, LL; Junker, AE | 1 |
| Macedo, CR; Macedo, EC; Prado, GF; Silva, AB; Torloni, MR | 1 |
| Goyal, RK; Jhala, MK; Joshi, CG; Patel, AK; Rana, DG | 1 |
| Amato, L; Davoli, M; De Crescenzo, F; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P | 1 |
| Broderick, PA; Li, YS; Wenning, L | 1 |
| Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C | 1 |
| Aslanoglou, D; Benner, V; Farino, ZJ; Freyberg, Z; Lopez-Valencia, M; McCarthy, MJ; Osborn, O; Wei, H; Zapata, RC | 1 |
| Huang, X; Mailman, RB; Yang, Y | 1 |
| Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C | 1 |
90 review(s) available for bromocriptine and levodopa
| Article | Year |
|---|---|
Medical treatment of acromegaly.
Topics: Acromegaly; Adrenergic alpha-Agonists; Bromocriptine; Estrogens; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Medroxyprogesterone; Serotonin Antagonists; Somatostatin | 1978 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Recent advances in research on Parkinsonism.
Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1978 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor | 1979 |
Treatment of acute hepatic encephalopathy.
Topics: Acid-Base Imbalance; Acute Disease; Adrenal Cortex Hormones; Antacids; Anti-Bacterial Agents; Blood Coagulation Disorders; Bromocriptine; Cimetidine; Critical Care; Cross Circulation; Diuretics, Osmotic; Exchange Transfusion, Whole Blood; Extracorporeal Circulation; Gastrointestinal Hemorrhage; Hemoperfusion; Hepatic Encephalopathy; Hepatitis B Antibodies; Humans; Lactulose; Levodopa; Liver Circulation; Liver Transplantation; Neomycin; Parenteral Nutrition; Peritoneal Dialysis; Plasma; Renal Dialysis; Serum Albumin; Transplantation, Homologous | 1979 |
Prolactin.
Topics: Amenorrhea; Animals; Behavior, Animal; Breast Neoplasms; Bromocriptine; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Levodopa; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Rats; Stress, Physiological; Tranquilizing Agents | 1978 |
Bromocriptine in Parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced | 1978 |
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine | 1979 |
Drug therapy: Bromocriptine.
Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
[Psychiatric manifestations induced by dopamine precursors or antagonists].
Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride | 1979 |
[Role of prolactin in carcinogenesis and growth of mammary and breast neoplasms in animals and in man].
Topics: Animals; Benz(a)Anthracenes; Breast; Breast Neoplasms; Bromocriptine; Cell Differentiation; Cell Transformation, Neoplastic; Female; Humans; Levodopa; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Prolactin | 1976 |
Drugs that affect the breast and lactation.
Topics: Androgens; Apomorphine; Barbiturates; Breast; Breast Neoplasms; Bromocriptine; Contraceptives, Oral, Hormonal; Estrogens; Female; Galactorrhea; Humans; Lactation; Levodopa; Male; Monoamine Oxidase Inhibitors; Nandrolone; Phenothiazines; Pregnancy; Progesterone; Prolactin; Psychotropic Drugs; Pyridoxine; Steroids | 1975 |
Drug therapy of Parkinson's disease. An overview.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease; Receptors, N-Methyl-D-Aspartate | 1992 |
[Current therapeutic approach in Parkinson disease].
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Selegiline; Vitamin E | 1992 |
The treatment of chronic hepatic encephalopathy.
Topics: Amantadine; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver Cirrhosis; Receptors, GABA-A | 1991 |
Review and videotape recognition of idiopathic restless legs syndrome.
Topics: Anti-Anxiety Agents; Arousal; Baclofen; Benzodiazepines; Bromocriptine; Carbamazepine; Clonidine; Humans; Levodopa; Narcotics; Restless Legs Syndrome; Sleep Stages; Videotape Recording | 1991 |
Neuroactive drugs in growth disorders.
Topics: Bromocriptine; Central Nervous System; Child; Clonidine; False Negative Reactions; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Pyridostigmine Bromide | 1990 |
[Dopanergic agonists and schizophrenia].
Topics: Bromocriptine; Dopamine Agents; Humans; Levodopa; Receptors, Dopamine; Schizophrenia | 1989 |
Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
Topics: Age Factors; Animals; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Haplorhini; Humans; Levodopa; Parasympatholytics; Reserpine; Risk | 1985 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
[Differential diagnosis of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin; Prolactin Release-Inhibiting Factors; Thyrotropin-Releasing Hormone | 1986 |
Chronic pharmacological manipulation of dopamine receptors in brain.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Bromocriptine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Pergolide; Receptors, Dopamine; Trifluoperazine | 1987 |
[Parkinson disease. The clinical picture and therapy].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease | 1988 |
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome | 1988 |
Clonidine treatment in children with short stature.
Topics: Body Height; Bromocriptine; Child; Clonidine; Growth Disorders; Growth Hormone; Humans; Levodopa | 1988 |
New perspectives in the treatment of Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Selegiline; Sincalide | 1986 |
'On-off' phenomenon: description, incidence and management.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Selegiline | 1987 |
Controversies in the management of Parkinson's disease.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Selegiline | 1986 |
Long-term use of dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors | 1985 |
The controversial role of bromocriptine in Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Time Factors | 1985 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
Update on the treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors | 1985 |
Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cyproheptadine; Ergolines; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Hypothalamus; Levodopa; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Update on antiparkinsonian agents.
Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance | 1982 |
Perspectives in hepatic encephalopathy.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver; Neurotransmitter Agents; Toxins, Biological | 1982 |
[Therapy of hepatic encephalopathy. Personal experience and a review of the literature].
Topics: Amino Acids; Ammonia; Bromocriptine; Electroencephalography; Fatty Acids; Hepatic Encephalopathy; Lactulose; Levodopa; Neomycin; Nervous System; Neurologic Examination; Neurotransmitter Agents; Sulfhydryl Compounds; Synaptic Transmission | 1982 |
Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
Topics: Animals; Benzazepines; Blood Pressure; Bromocriptine; Domperidone; Dopamine; Ergolines; Fenoldopam; Humans; Hypertension; Levodopa; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasoconstriction; Vasodilation | 1984 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
Prolactin-producing pituitary tumors: medical therapy.
Topics: Bromocriptine; Female; Humans; Levodopa; Pituitary Neoplasms; Prolactin | 1980 |
On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Bromocriptine; Humans; Hydroxydopamines; Levodopa; Receptors, Dopamine | 1980 |
[Antiestrogens in the treatment of breast cancer].
Topics: Adult; Blood Proteins; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Estrogen Antagonists; Female; Homeostasis; Humans; Levodopa; Ligands; Male; Menopause; Middle Aged; Tamoxifen | 1981 |
Is aldosterone secretion under dopaminergic control?
Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; Methyldopa; Metoclopramide; Parkinson Disease; Sulpiride | 1981 |
The management of Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease | 1982 |
[Stage-adjusted treatment of idiopathic Parkinson syndrome].
Topics: Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Cholinergic Antagonists; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Selegiline | 1995 |
Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages.
Topics: Animals; Brain; Bromocriptine; Corpus Striatum; Dopamine Agonists; Free Radicals; Humans; Levodopa; Mice; Parkinson Disease; Parkinson Disease, Secondary; Premedication; Reactive Oxygen Species; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 1994 |
[Recent progress of therapy in patients with Parkinson's disease].
Topics: Brain; Bromocriptine; Delayed-Action Preparations; Droxidopa; Drug Resistance; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine | 1993 |
Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Topics: Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome | 1993 |
Treatment of early Parkinson's disease: are complicated strategies justified?
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline | 1996 |
Drug management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl | 1996 |
New directions in the drug treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Selegiline | 1996 |
[Treatment of Parkinson's disease with multiple drugs].
Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide | 1997 |
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic | 1998 |
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders | 1999 |
The initial treatment of Parkinson's disease should begin with levodopa.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors | 1999 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide | 2000 |
Bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease | 2000 |
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease | 2000 |
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2000 |
Bromocriptine versus levodopa in early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2000 |
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles | 2000 |
[The new Parkinson's disease drugs].
Topics: Antiparkinson Agents; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease | 2000 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2001 |
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2001 |
Clinical management of neuroleptic malignant syndrome.
Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty | 2001 |
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2002 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Contraindications; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 2002 |
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis | 2002 |
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone | 2004 |
Ropinirole: current status of the studies.
Topics: Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease | 2004 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury.
Topics: Amantadine; Animals; Brain Injuries; Bromocriptine; Cognition Disorders; Dextroamphetamine; Humans; Levodopa; Methylphenidate | 2005 |
Bromocriptine versus levodopa in early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2007 |
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2007 |
Treatment of portal systemic encephalopathy: standard and new treatments.
Topics: Bromocriptine; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Double-Blind Method; Enema; GABA Antagonists; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Laxatives; Levodopa; Liver Cirrhosis; Malnutrition; Metabolic Networks and Pathways; Plant Proteins, Dietary; Sodium Benzoate; Zinc | 1990 |
Acute management of acquired brain injury Part III: an evidence-based review of interventions used to promote arousal from coma.
Topics: Amantadine; Arousal; Brain Injuries; Bromocriptine; Coma, Post-Head Injury; Dopamine Agonists; Evidence-Based Medicine; Humans; Levodopa; Music Therapy; Randomized Controlled Trials as Topic; Recovery of Function | 2010 |
Dopamine agonists for the treatment of cocaine dependence.
Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic | 2011 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
Dopamine agents for hepatic encephalopathy.
Topics: Bromocriptine; Dopamine Agonists; Hepatic Encephalopathy; Humans; Levodopa; Randomized Controlled Trials as Topic | 2014 |
Pharmacotherapy for sleep bruxism.
Topics: Amitriptyline; Bromocriptine; Clonidine; Humans; Levodopa; Propranolol; Randomized Controlled Trials as Topic; Sleep Bruxism; Tryptophan | 2014 |
Dopamine agonists for the treatment of cocaine dependence.
Topics: Amantadine; Antidepressive Agents; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic; Selection Bias | 2015 |
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.
Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes | 2017 |
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole | 2023 |
118 trial(s) available for bromocriptine and levodopa
| Article | Year |
|---|---|
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Topics: Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Levodopa; Receptors, Dopamine; Schizophrenia; Time Factors; Trihexyphenidyl | 1978 |
Letter: Bromocriptine in parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Levodopa; Parkinson Disease | 1975 |
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors | 1976 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piperidines; Thioxanthenes; Trihexyphenidyl | 1978 |
Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
Topics: Adult; Bromocriptine; Carbidopa; Chlorpromazine; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Placebos; Prolactin; Time Factors | 1978 |
An ergot derivative in the treatment of Parkinson's disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Parkinson Disease | 1976 |
Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
Topics: Animals; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease, Secondary; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1978 |
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
Topics: Administration, Oral; Adolescent; Adult; Benserazide; Bromocriptine; Clinical Trials as Topic; Drug Interactions; Ergolines; Female; Humans; Hydrazines; Levodopa; Male; Metergoline; Methysergide; Middle Aged; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Stimulation, Chemical; Time Factors | 1977 |
[Treatment of parkinsonian syndromes by bromocriptin].
Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary | 1977 |
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Individuality; Levodopa; Male; Middle Aged; Parkinson Disease | 1977 |
Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos | 1977 |
Bromocriptine in the treatment of advanced Parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos | 1977 |
Treatment of Parkinson's disease with lergotrile mesylate.
Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease | 1977 |
Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Placebos; Psychiatric Status Rating Scales | 1978 |
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents | 1978 |
Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Syndrome | 1978 |
A double-blind trial of bromocriptine in Parkinson's disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1978 |
An evaluation of bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 1978 |
Inhibition of cimetidine-induced hyperprolactinaemia by pretreatment with levodopa or bromocriptine.
Topics: Adult; Bromocriptine; Cimetidine; Guanidines; Humans; Levodopa; Male; Middle Aged; Prolactin | 1979 |
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1976 |
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor | 1976 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting | 1977 |
Dopaminergic agonists in Parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos | 1975 |
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease | 1992 |
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment.
Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report.
Topics: Benserazide; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease; Prospective Studies; Psychomotor Performance | 1992 |
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report.
Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies | 1992 |
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
Topics: Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Performance | 1992 |
Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception | 1992 |
Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO.
Topics: Administration, Oral; Aged; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl | 1992 |
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.
Topics: Adult; Aged; Aged, 80 and over; Behavior; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1991 |
A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease | 1991 |
Simplification of the initiation of bromocriptine in elderly patients with advanced Parkinson's disease.
Topics: Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1991 |
Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Japan; Levodopa; Middle Aged; Multicenter Studies as Topic; Parkinson Disease | 1990 |
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic | 1990 |
Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease | 1990 |
Adjunctive therapy with bromocriptine in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1990 |
Long-term double masked trial of early treatment with L-dopa plus bromocriptine versus L-dopa alone in Parkinson's disease. Interim results.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease, Secondary | 1990 |
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline | 1989 |
Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer.
Topics: Aged; Blood Glucose; Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Growth Hormone; Hormones; Humans; Insulin-Like Growth Factor I; Levodopa; Middle Aged; Pilot Projects; Prolactin; Prospective Studies; Somatostatin | 1989 |
The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1989 |
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation | 1989 |
The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Gait; Humans; Levodopa; Middle Aged; Parkinson Disease | 1989 |
Long term bromocriptine treatment in de novo parkinsonian patients.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1988 |
A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Parkinson Disease; Random Allocation | 1988 |
A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease; Prospective Studies | 1988 |
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Neurologic Examination; Parkinson Disease | 1987 |
A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies | 1988 |
Patients sought for New Zealand multi-centre Parkinson's disease trial.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; New Zealand; Parkinson Disease | 1987 |
Restless legs syndrome treatment with dopaminergic drugs.
Topics: Adult; Aged; Benserazide; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Piribedil; Random Allocation; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders | 1987 |
Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1987 |
Treatment of early morning akinesia with low-dose bromocriptine.
Topics: Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1987 |
The Sydney multicentre study of Parkinson's disease. The first 18 months.
Topics: Australia; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Levodopa; Parkinson Disease | 1987 |
Bromocriptine and the clinical spectrum of Parkinson's disease.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1987 |
Low dosages of bromocriptine added to levodopa in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1985 |
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1982 |
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
Topics: Aged; Benserazide; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Random Allocation; Time Factors | 1984 |
Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
Topics: Adult; Apomorphine; Benztropine; Bromocriptine; Cholinergic Fibers; Dopamine; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Penis | 1984 |
Pergolide in late-stage Parkinson disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders | 1982 |
Prolactin secretion in Parkinson disease.
Topics: Adult; Aged; Blood-Brain Barrier; Bromocriptine; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Hypothalamus, Anterior; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Placebos; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1981 |
Assessment of hypokinesia in Parkinsonism.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors | 1981 |
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.
Topics: Bromocriptine; Carbidopa; Clinical Trials as Topic; Follow-Up Studies; Humans; Levodopa; Parkinson Disease | 1981 |
The effect of bromocriptine (BCT) on the on-off phenomenon.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease | 1981 |
Weekly drug holiday in Parkinson disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
Bromocriptine and domperidone in the treatment of Parkinson disease.
Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting | 1981 |
Bromocriptine: low-dose therapy in Parkinson disease.
Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor | 1982 |
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome | 1995 |
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome | 1994 |
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease | 1994 |
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure | 1994 |
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
Topics: Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Prospective Studies | 1994 |
Visual control of arm movement in Parkinson's disease.
Topics: Adult; Aged; Attention; Benserazide; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Orientation; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline | 1994 |
Progress note on Japanese multicenter bromocriptine monotherapy.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease | 1993 |
Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Selegiline; Treatment Outcome | 1993 |
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1993 |
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors | 1993 |
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor | 1995 |
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Cause of Death; Disability Evaluation; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Selegiline; Time Factors; Treatment Failure | 1995 |
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon | 1995 |
Bromocriptine therapy in early-stage Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disease Progression; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Time Factors; Treatment Outcome | 1996 |
Age at onset: the major determinant of outcome in Parkinson's disease.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Postural Balance; Treatment Outcome; Tremor | 1995 |
Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease | 1996 |
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Parkinson Disease; Prospective Studies; Time Factors | 1996 |
Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Placebos; Prospective Studies | 1997 |
Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1997 |
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone | 1997 |
Discontinuation of prolonged bromocriptine therapy in Parkinson's disease patients with uncontrolled motor oscillations.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies | 1994 |
Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1997 |
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index | 1997 |
Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.
Topics: Administration, Oral; Adult; Analysis of Variance; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Electromyography; Evoked Potentials, Motor; Female; Haloperidol; Humans; Levodopa; Magnetics; Male; Motor Cortex; Physical Stimulation; Reference Values; Selegiline; Sulpiride | 1997 |
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry
Topics: Antiparkinson Agents; Bromocriptine; Cause of Death; Disabled Persons; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Proportional Hazards Models; Selegiline; Survival Rate; Treatment Failure | 1998 |
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?
Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome | 1997 |
Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group.
Topics: Aged; Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome | 1999 |
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1999 |
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome | 2000 |
Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.
Topics: Aged; Blood Pressure; Bromocriptine; Cardiovascular System; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline | 2000 |
Suppressed sympathetic skin response in Parkinson disease.
Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Electric Stimulation; Evoked Potentials; Evoked Potentials, Auditory; Female; Foot; Hand; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time; Reference Values; Selegiline; Skin; Sympathetic Nervous System | 2000 |
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Levodopa; Male; Middle Aged; Mortality; Parkinson Disease; Prospective Studies; Treatment Outcome | 2001 |
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial.
Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Disability Evaluation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Parkinson Disease; Selegiline; Treatment Outcome | 2001 |
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease | 2002 |
Ropinirole for the treatment of tremor in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor | 2002 |
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Treatment Outcome | 2002 |
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Withholding Treatment | 2002 |
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Treatment Outcome | 2003 |
Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.
Topics: Acoustic Stimulation; Adult; Brain; Bromocriptine; Cross-Over Studies; Dopamine Agents; Dopamine Agonists; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Homovanillic Acid; Humans; Levodopa; Male; Prolactin; Sensory Deprivation; Time Factors | 2004 |
No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
Topics: Adult; Antiparkinson Agents; Attention; Bromocriptine; Cross-Over Studies; Dopamine; Dopamine Agonists; Double-Blind Method; Electroencephalography; Electrooculography; Event-Related Potentials, P300; Homovanillic Acid; Humans; Levodopa; Male; Prolactin; Psychomotor Performance; Psychophysiology; Receptors, Dopamine D2 | 2006 |
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Quality of Life; Selegiline | 2008 |
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult | 2009 |
Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Rheology; Severity of Illness Index; Statistics, Nonparametric; Urinary Bladder Diseases; Urodynamics | 2009 |
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
415 other study(ies) available for bromocriptine and levodopa
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase | 1977 |
Update on drug treatment of Parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1977 |
The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
Topics: Acetonitriles; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Ergot Alkaloids; Female; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors | 1978 |
Dopaminephilic properties of ergot alkaloids.
Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase | 1978 |
Lergotrile in Parkinson disease: further studies.
Topics: Aged; Bromocriptine; Chemical Phenomena; Chemistry; Dopa Decarboxylase; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease | 1979 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
Letter: Prolactin, levodopa, and migraine.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Migraine Disorders; Prolactin | 1975 |
Letter: Growth-hormone responses in Parkinson's disease.
Topics: Bromocriptine; Growth Hormone; Humans; Levodopa; Parkinson Disease | 1976 |
Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
Topics: Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia, Paranoid | 1976 |
Long-term treatment of parkinsonism with bromocriptine.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Time Factors | 1978 |
Drugs for Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenethylamines | 1978 |
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.
Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Sleep | 1978 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1978 |
Tests of prolactin secretion in diagnosis of prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Metoclopramide; Paraneoplastic Endocrine Syndromes; Pituitary Function Tests; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1979 |
Chronic autonomic failure with postural hypotension.
Topics: Autonomic Nervous System; Blood Pressure; Bromocriptine; Cardiovascular System; Chronic Disease; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Nerve Degeneration; Nervous System Diseases; Pressoreceptors | 1979 |
Prolactin and the encephalopathy of Reye's syndrome.
Topics: Bromocriptine; Cerebral Ventricles; Child; Dopamine; Epinephrine; Female; Hepatic Encephalopathy; Humans; Hypothalamus; Levodopa; Male; Norepinephrine; Prolactin; Reye Syndrome; Tyramine | 1979 |
[The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
Topics: Acromegaly; Adult; Aged; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Thyrotropin-Releasing Hormone | 1978 |
Altered hypothalamic-pituitary function in uraemic patients [proceedings].
Topics: Adolescent; Adult; Bromocriptine; Female; Gonadotropins, Pituitary; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Metoclopramide; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Uremia | 1978 |
Behavioral evidence for supersensitivity after chronic bromocriptine administration.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Drug Tolerance; Female; Humans; Levodopa; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine; Stereotyped Behavior | 1979 |
Human pituitary adenomas with hypersecretion of TSH and prolactin. Evidence that receptor sites for dopamin may be absent on TSH producing while present on prolactin producing cells.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperthyroidism; Levodopa; Male; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone | 1979 |
The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Topics: Adult; Bromocriptine; Chlorpromazine; Female; Follicular Phase; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1979 |
Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
Topics: Acromegaly; Aged; Animals; Bromocriptine; Dopamine; Drug Interactions; Female; Growth Hormone; Humans; Levodopa; Liver Cirrhosis; Male; Median Eminence; Middle Aged; Prolactin; Rats; Thyrotropin-Releasing Hormone; Time Factors | 1979 |
Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
Topics: Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline | 1979 |
Role of dopaminergic receptors in the regulation of growth hormone secretion.
Topics: Adult; Aged; Animals; Bromocriptine; Dextroamphetamine; Dopamine; Female; Growth Hormone; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Neural Pathways; Prolactin; Rats; Receptors, Dopamine; Time Factors | 1977 |
Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
Topics: Adult; Apomorphine; Bromocriptine; Female; Growth Hormone; Humans; Huntington Disease; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Receptors, Dopamine | 1979 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
In practice. Parkinson's disease.
Topics: Amantadine; Basal Ganglia; Bromocriptine; Humans; Levodopa; Middle Aged; Movement; Parasympatholytics; Parkinson Disease; Prognosis; Synaptic Transmission | 1979 |
Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man.
Topics: Adult; Bromocriptine; Drug Synergism; Feedback; Growth Hormone; Humans; Levodopa; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1979 |
Adenosine 3':5'-monophosphate-dependent in vitro phosphorylation of synaptosomal membrane proteins from rat corpus striatum following systemic administration of L-DOPA and bromocriptine.
Topics: Animals; Benserazide; Bromocriptine; Corpus Striatum; Cyclic AMP; In Vitro Techniques; Levodopa; Membrane Proteins; Phosphorylation; Rats; Stimulation, Chemical; Synaptic Membranes | 1979 |
Opiates, prolactin, and the dopamine receptor.
Topics: Apomorphine; Bromocriptine; Chlorpromazine; Cyproheptadine; Heroin Dependence; Humans; Kinetics; Levodopa; Methadone; Morphine; Prolactin; Receptors, Dopamine | 1978 |
Bromocriptine and parkinsonism.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1978 |
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
Topics: Adult; Bromocriptine; Carbidopa; Chronic Disease; Humans; Levodopa; Locus Coeruleus; Male; Meperidine; Opioid-Related Disorders; Parkinson Disease, Secondary; Substantia Nigra | 1979 |
Functional delineation of hyperprolactinemic-amenorrhea.
Topics: Adenoma; Adult; Amenorrhea; Androgens; Bromocriptine; Dopamine; Estrogens; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hydrocortisone; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1977 |
[Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment].
Topics: Acromegaly; Adult; Bromocriptine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Thyrotropin-Releasing Hormone | 1977 |
Radioimmunoassay of thyrotrophin-releasing hormone (TRH) in normal subjects, in abnormal thyroid states and under catecholaminergic influences.
Topics: Adenoma; Adult; Bromocriptine; Child; Chlorpromazine; Female; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Levodopa; Male; Pituitary Neoplasms; Pregnancy; Radioimmunoassay; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1978 |
Parkinson's disease: search for better therapies.
Topics: Bromocriptine; Humans; Levodopa; Oligopeptides; Parkinson Disease; Receptors, Dopamine | 1979 |
Long-term treatment of Parkinson's disease with bromocriptine.
Topics: Adult; Age Factors; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1979 |
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease, Secondary; Receptors, Dopamine | 1979 |
Drugs for parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1979 |
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone | 1979 |
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan | 1979 |
In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Topics: Adenoma; Bromocriptine; Cells, Cultured; Dopamine; Growth Hormone; Humans; Levodopa; Pituitary Neoplasms; Prolactin | 1979 |
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.
Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Reticular Formation; Sleep | 1979 |
Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading.
Topics: Bromocriptine; Dopamine beta-Hydroxylase; Humans; Kinetics; Levodopa; Parkinson Disease | 1979 |
[Comparative action of L-dopa and bromocriptine on thyreostimulating hormone (T.S.H.) in primary hypothyroïdism (author's transl)].
Topics: Adult; Aged; Bromocriptine; Female; Humans; Hypothyroidism; Levodopa; Male; Middle Aged; Sex Factors; Thyrotropin; Time Factors | 1979 |
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior | 1977 |
The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
Topics: Acetonitriles; Animals; Brain Chemistry; Bromocriptine; Copper; Ergolines; Guinea Pigs; Iron; Levodopa; Male; Manganese; Metals | 1978 |
Bromocriptine in Parkinson disease: further studies.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1979 |
The role of bromocriptine in the treatment of parkinsonism.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1979 |
Activity of bromoergocryptine, Mucuna pruriens and L-dopa in the control of hyperprolactinaemia.
Topics: Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; Plants, Medicinal; Pregnancy; Prolactin | 1978 |
Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Levodopa; Luteinizing Hormone; Phenothiazines; Pregnancy; Prolactin | 1978 |
The inhibitory effect of dopamine agonists on LH release in women.
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Prolactin | 1977 |
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin | 1977 |
Treatment of Parkinson's disease with bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease | 1977 |
Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Levodopa; Male; Metergoline; Pimozide; Prolactin; Sulpiride | 1977 |
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.
Topics: Aged; Benserazide; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease | 1977 |
The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
Topics: Adult; Apomorphine; Bromocriptine; Chlorpromazine; Female; Humans; Levodopa; Pituitary Gland | 1977 |
[Long-term administration of CB-154 in acromegaly].
Topics: Acromegaly; Adult; Aged; Bromocriptine; Depression, Chemical; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged | 1977 |
[Endocrinological aspects of the dopaminergic control of somatotropin in patients with acromegaly].
Topics: Acromegaly; Adult; Bromocriptine; Female; Glycogen; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Middle Aged | 1977 |
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bromocriptine; Depression; Female; Hostility; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Piperazines; Piribedil; Receptors, Dopamine; Syndrome | 1978 |
Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs.
Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Dopamine; Hydroxydopamines; Hypothalamus; Hypothalamus, Anterior; Levodopa; Male; Models, Neurological; Motor Activity; Norepinephrine; Piribedil; Rats; Receptors, Dopamine; Serotonin; Tyrosine | 1978 |
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine | 1978 |
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.
Topics: Aged; Benzimidazoles; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1978 |
Comparison between lergotrile and bromocriptine in parkinsonism.
Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1978 |
Bromocriptine in parkinsonism. A long-term study.
Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System | 1978 |
Prolactin clearance rates in male rats.
Topics: Animals; Bromocriptine; Levodopa; Male; Metabolic Clearance Rate; Prolactin; Rats | 1978 |
[Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
Topics: Adenoma; Bromocriptine; Depression, Chemical; Dopamine; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Prolactin | 1978 |
Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
Topics: Benserazide; Brain; Bromocriptine; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1978 |
Bromocriptine in Parkinson's disease.
Topics: Bromocriptine; Humans; Levodopa; Parkinson Disease | 1978 |
[Significance of blood levels of prolactin and somatotropin as indices of pharmacological effects on the central nervous system].
Topics: Adult; Brain; Bromocriptine; Growth Hormone; Humans; Levodopa; Male; Pharmacology; Phospholipids; Piracetam; Prolactin; Receptors, Dopamine | 1978 |
Overview of present day treatment of Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Receptors, Dopamine; Selegiline | 1978 |
Bromocriptine in lieu of levodopa for Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease | 1978 |
[Prolactin and breast cancer].
Topics: Adult; Animals; Breast Neoplasms; Bromocriptine; Carcinogens; Female; Humans; Lactation; Levodopa; Mice; Ovary; Pituitary Gland; Pregnancy; Prolactin; Rats | 1975 |
Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation.
Topics: Amino Acids; Bromocriptine; Clomiphene; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hypothalamo-Hypophyseal System; Insulin; Lactation Disorders; Levodopa; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Psychotropic Drugs; Stimulation, Chemical; Thyrotropin-Releasing Hormone; Water | 1975 |
A neuropharmacological approach to experimental bruxism.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Bruxism; Drug Synergism; Levodopa; Male; Mastication; Methylphenidate; Piribedil; Rats; Scopolamine; Theophylline; Time Factors | 1977 |
Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
Topics: Acetylcholine; Animals; Apomorphine; Benserazide; Bromocriptine; Cats; Cerebral Cortex; Dopamine; Female; Haloperidol; Levodopa; Male; Parasympathetic Nervous System; Rats; Time Factors | 1977 |
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia | 1977 |
[Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
Topics: Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1977 |
Brain dopamine turnover and the relief of parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parkinson Disease; Piperazines; Piribedil; Probenecid; Receptors, Dopamine | 1977 |
Treatment of parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 1977 |
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra | 1976 |
Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
Topics: Acromegaly; Adult; Amenorrhea; Bromocriptine; Chorionic Gonadotropin; Female; Follicle Stimulating Hormone; Galactorrhea; Growth Hormone; Humans; Lactation Disorders; Levodopa; Luteinizing Hormone; Ovulation; Pregnancy; Pregnancy Complications; Prolactin | 1976 |
Studies with bromocriptine. Part 1. "On-off" phenomena.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease; Reflex | 1976 |
Treatment of parkinson's disease with bromocriptine.
Topics: Aged; Bromocriptine; Delusions; Dopa Decarboxylase; Drug Evaluation; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Growth hormone and prolactin release in acromegalic patients following metergoline administration.
Topics: Acromegaly; Adult; Animals; Bromocriptine; Ergolines; Growth Hormone; Humans; Levodopa; Male; Metergoline; Middle Aged; Prolactin; Serotonin; Serotonin Antagonists | 1976 |
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1976 |
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol | 1975 |
Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Hypothalamus; Levodopa; Male; Metoclopramide; Pituitary Gland; Prolactin | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
Editorial: Alternatives to levodopa.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease | 1976 |
Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
Topics: Adult; Bromocriptine; Calcium Channels; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Verapamil | 1992 |
Postvaccinal parkinsonism.
Topics: Bromocriptine; Child, Preschool; Dose-Response Relationship, Drug; Encephalomyelitis, Acute Disseminated; Humans; Levodopa; Magnetic Resonance Imaging; Male; Measles Vaccine; Neurologic Examination; Parkinson Disease, Postencephalitic; Substantia Nigra | 1992 |
Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline.
Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agents; Humans; Levodopa; Middle Aged; Parkinson Disease; Selegiline | 1992 |
[Clozapine, a valuable contribution for the treatment of psychoses in Parkinson disease].
Topics: Aged; Bromocriptine; Clozapine; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced | 1992 |
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Interactions; Female; Half-Life; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1992 |
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
Topics: Aged; Anthropometry; Body Composition; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Nutrition Assessment; Parkinson Disease; Reference Values; Sex Characteristics; Weight Loss | 1992 |
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.
Topics: Aged; Bromocriptine; Carbidopa; Combined Modality Therapy; Fabaceae; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Plants, Medicinal | 1992 |
A component analysis of the generation and release of isometric force in Parkinson's disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Muscles; Neurologic Examination; Parkinson Disease; Reaction Time; Trihexyphenidyl | 1992 |
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone | 1991 |
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease.
Topics: Aged; Aging; Blood Pressure; Bromocriptine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Piribedil; Receptors, Adrenergic, beta | 1991 |
[The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Somatostatin | 1990 |
The influence of bromocriptine on the pharmacokinetics of levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1991 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl | 1991 |
[Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
Topics: Analysis of Variance; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1991 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Treating the progressive stages of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline | 1991 |
Hyperprolactinemia in multiple sclerosis.
Topics: Adult; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothalamus; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1991 |
Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance Withdrawal Syndrome | 1991 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Bromocriptine; Ceruletide; Dyskinesia, Drug-Induced; Levodopa; Male; Neurotoxins; Neurotransmitter Agents; Nitriles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic | 1990 |
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Brain; Bromocriptine; Carbidopa; Catecholamines; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Receptors, Dopamine; Spiperone | 1990 |
Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benserazide; Bromocriptine; Child; Dopamine Agents; Drug Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Nausea; Restless Legs Syndrome; Time Factors | 1990 |
Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.
Topics: Administration, Oral; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1991 |
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
Topics: Aged; Blood Pressure; Bromocriptine; Epinephrine; Female; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture | 1991 |
Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Topics: Aged; Benserazide; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Serotonin | 1990 |
A view from inside.
Topics: Accidental Falls; Antiparkinson Agents; Bromocriptine; Carbidopa; Dentists; Drug Combinations; Humans; Levodopa; Male; Northern Ireland; Parkinson Disease | 1990 |
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone | 1990 |
[The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease | 1990 |
Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's disease.
Topics: Administration, Oral; Aged; Amantadine; Biperiden; Bromocriptine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Piperidines | 1990 |
Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Bromocriptine; Catecholamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Prolactin; Pyridines | 1986 |
Parkinson disease: electrophysiological (CNV) analysis related to pharmacological treatment.
Topics: Bromocriptine; Contingent Negative Variation; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1986 |
Early dopamine agonist therapy in Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine | 1989 |
The influence of levodopa in the pharmacokinetics of bromocriptine in Parkinson's disease.
Topics: Adjuvants, Pharmaceutic; Aged; Bromocriptine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1989 |
Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1989 |
Falls and Parkinson's disease.
Topics: Accidental Falls; Accidents; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Parkinson Disease; Physical Therapy Modalities; Posture; Risk Factors | 1989 |
Subcutaneous apomorphine in Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease | 1989 |
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echolalia; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease | 1989 |
[L-dopa, biperiden and sebum excretion in Parkinson disease].
Topics: Aged; Aged, 80 and over; Aromatic-L-Amino-Acid Decarboxylases; Biperiden; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Sebum; Sex Factors | 1989 |
A community survey of Parkinson's disease.
Topics: Aged; British Columbia; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rural Population | 1989 |
The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Body Temperature; Bromocriptine; Dextroamphetamine; Dopamine; Levodopa; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Dopamine; Stereotyped Behavior | 1989 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance | 1985 |
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Bromocriptine; Bupropion; Central Nervous System Stimulants; Cues; Generalization, Stimulus; Levodopa; Male; Nomifensine; Propiophenones; Rats; Receptors, Dopamine; Viloxazine | 1985 |
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan | 1985 |
Effect of somatostatin and dopaminergic agents on bovine pituitary phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Bromocriptine; Cattle; Dopamine; Kinetics; Levodopa; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Somatostatin | 1986 |
Parkinson's disease, depression, and the on-off phenomenon.
Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1989 |
Comprehensive care of the patient with Parkinson's disease.
Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor | 1986 |
Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
Topics: Acetylcholine; Adult; beta-Endorphin; beta-Lipotropin; Blood-Brain Barrier; Bromocriptine; Dexamethasone; Domperidone; Dopamine; Humans; Levodopa; Male; Metoclopramide; Nomifensine; Reference Values | 1988 |
Increase of rat serum prolactin by adenosine analogs and their blockade by the methylxanthine aminophylline.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); alpha-Methyltyrosine; Aminophylline; Animals; Bromocriptine; Corpus Striatum; Haloperidol; In Vitro Techniques; Levodopa; Male; Methyltyrosines; Phenylisopropyladenosine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment.
Topics: Aged; Blood Platelets; Bromocriptine; Cell Membrane; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Platelet Aggregation; Receptors, Adrenergic, alpha; Yohimbine | 1985 |
Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
Topics: Bromocriptine; Child; Child, Preschool; Dopamine; Estradiol; Female; Follicle Stimulating Hormone; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Male; Testosterone; Thyroxine | 1986 |
Function of dopamine receptors in Parkinson's disease: prolactin responses.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone; Time Factors | 1986 |
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease | 1986 |
Current and future approaches to therapy.
Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline | 1987 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease | 1987 |
Parkinson's disease in the elderly: current management strategies.
Topics: Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline | 1987 |
In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Chlorpromazine; Depression, Chemical; Female; Growth Hormone; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Prolactin; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1987 |
Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Topics: Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Levodopa; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin | 1987 |
Dynamics of growth hormone secretion in untreated acromegaly.
Topics: Acromegaly; Adult; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Middle Aged; Thyrotropin-Releasing Hormone | 1987 |
A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
Topics: Aged; Alzheimer Disease; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamus; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1986 |
Milestones in the development of modern Parkinson therapy.
Topics: 2,3-Diketogulonic Acid; Alloxan; Behavior; Bromocriptine; Drug Combinations; Drug Therapy, Combination; Ferric Compounds; Humans; Levodopa; Neurology; Parkinson Disease; Selegiline; Tryptophan | 1987 |
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior | 1988 |
Drugs for parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline | 1988 |
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
Topics: Adult; Aged; Apomorphine; Blood Pressure; Bromocriptine; Cardiovascular System; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Heart Rate; Hemodynamics; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Pulse; Sympathetic Nervous System | 1985 |
Studies of the thyrotropic function of the adenopituitary of the offspring of rats treated during pregnancy with dopaminergic agents.
Topics: Animals; Bromocriptine; Female; Haloperidol; Levodopa; Male; Pituitary Gland, Anterior; Pregnancy; Rats; Rats, Inbred Strains; Thyrotropin | 1988 |
[Emetic and catalepsy-inducing actions of buflomedil].
Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationship, Drug; Levodopa; Male; Mice; Pyrrolidines; Vomiting | 1988 |
Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
Topics: Adolescent; Adult; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Muscular Dystrophies; Prolactin; Sulpiride | 1988 |
Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1988 |
International symposium on early dopamine agonist therapy of Parkinson's disease.
Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors | 1988 |
Lack of pharmacokinetic influence on levodopa by bromocriptine.
Topics: Bromocriptine; Carbidopa; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1988 |
Bromocriptine therapy in striatonigral degeneration.
Topics: Aged; Bromocriptine; Humans; Levodopa; Male; Nerve Degeneration; Parkinson Disease, Secondary; Putamen; Substantia Nigra | 1988 |
Outpatient treatment of Parkinson's disease.
Topics: Ambulatory Care; Benserazide; Bromocriptine; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Retrospective Studies | 1988 |
[Nursing homes patients with Parkinson disease: treatment].
Topics: Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Nursing Homes; Parkinson Disease | 1988 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
A pharmacological study of hibernation in rodents.
Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae | 1988 |
Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.
Topics: Animals; Behavior, Animal; Benserazide; Bromocriptine; Corpus Striatum; Denervation; Female; In Vitro Techniques; Levodopa; Rats; Receptors, Dopamine; Spiperone | 1987 |
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Recurrence; Trihexyphenidyl | 1987 |
The influence of dopamine agonists and antagonists on gastric lesions in mice.
Topics: Animals; Bromocriptine; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C3H; Pylorus; Stomach Ulcer | 1987 |
Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
Topics: Aged; Aged, 80 and over; Bromocriptine; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Levodopa; Middle Aged; Parkinson Disease | 1986 |
Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Bromocriptine; Butyrophenones; Female; Kinetics; Levodopa; Macaca fascicularis; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Spiperone; Time Factors | 1986 |
MPTP toxicity: clinical features.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Bromocriptine; California; Chemical Industry; District of Columbia; Female; Humans; Levodopa; Male; Occupational Diseases; Parkinson Disease, Secondary; Pyridines | 1986 |
Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 1987 |
Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
Topics: Administration, Oral; Aged; Bromocriptine; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Regional Blood Flow; Tomography, Emission-Computed | 1987 |
Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin; Levodopa; Pituitary Neoplasms | 1986 |
[Antiparkinson agents].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Lisuride; Parasympatholytics | 1987 |
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
Topics: Bromocriptine; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Parkinson Disease | 1987 |
[Bromocriptine and L-dopa therapy: comparison in a case of hereditary progressive dystonia with marked diurnal fluctuations].
Topics: Adolescent; Bromocriptine; Dystonia; Female; Humans; Levodopa | 1987 |
Excessive yawning and progressive supranuclear palsy.
Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Supranuclear Palsy, Progressive; Yawning | 1987 |
Ocular motor and manual tracking in Parkinson's disease and the effect of treatment.
Topics: Adult; Aged; Bromocriptine; Eye Movements; Female; Hand; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Reaction Time; Saccades | 1987 |
Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.
Topics: Aged; Bromocriptine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1987 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
[Experience with the use of parlodel in the treatment of Parkinson patients].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary | 1986 |
Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor | 1986 |
Pharmacotherapy: problems and practices.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1986 |
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.
Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Serotonin | 1986 |
Drugs for parkinsonism.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1986 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
[Revision of the treatment strategy in Parkinson disease].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Care Planning | 1986 |
Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding.
Topics: Animals; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Hypothalamus; Injections; Injections, Intraventricular; Levodopa; Male; Neurotensin; Rats; Rats, Inbred Strains; Time Factors | 1986 |
[Therapy of portosystemic encephalopathy].
Topics: Amino Acids, Branched-Chain; Ammonia; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Neomycin | 1986 |
The drug treatment of parkinsonism.
Topics: Bromocriptine; Carboxy-Lyases; Dopamine; Humans; Levodopa; Parkinson Disease | 1986 |
Management of Parkinson's disease in general practice.
Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease | 1986 |
Effect of antacid on levodopa therapy.
Topics: Aluminum Hydroxide; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Levodopa; Magnesium; Magnesium Hydroxide; Parkinson Disease | 1986 |
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine | 1986 |
Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Topics: Acromegaly; Adult; Blood-Brain Barrier; Bromocriptine; Domperidone; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride | 1987 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Dopamine antagonists induce gastric lesions in rats.
Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Metoclopramide; Rats; Rats, Inbred Strains; Stomach Ulcer | 1986 |
[Combination treatment in the early stages of Parkinson's disease].
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1987 |
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1987 |
Tracers for paralysis agitans in epidemiological research. IV. Trends in national drug policy and measurement of the prevalence of the disease in Sweden.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Antiparkinson Agents; Bromocriptine; Child; Child, Preschool; Drug Utilization; Epidemiologic Methods; Female; Humans; Infant; Infant Mortality; Levodopa; Male; Middle Aged; Parkinson Disease; Probability; Sweden; Time Factors | 1985 |
Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C57BL; Nomifensine; Pyridines | 1985 |
Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biogenic Amines; Brain Chemistry; Bromocriptine; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; Movement; Parkinson Disease, Secondary; Pyridines | 1985 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
[Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
Topics: Adolescent; Adult; Blood Glucose; Bromocriptine; Female; Growth Hormone; Humans; Hypothyroidism; Insulin; Levodopa; Male; Middle Aged; Prolactin | 1985 |
Parkinson disease. Individualizing therapy.
Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1985 |
Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
Topics: Age Determination by Skeleton; Bromocriptine; Child, Preschool; Estradiol; Female; Fetal Growth Retardation; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Male; Pregnancy; Somatomedins; Testosterone; Thyrotropin; Thyroxine | 1985 |
[Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Haloperidol; Levodopa; Male; Pituitary Gland; Rats; Thyrotropin; Thyrotropin-Releasing Hormone | 1985 |
Gigantism associated with McCune-Albright's syndrome.
Topics: Adolescent; Bromocriptine; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Gigantism; Growth Hormone; Humans; Levodopa; Male; Radiography; Radionuclide Imaging; Thyrotropin-Releasing Hormone | 1985 |
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Topics: Apomorphine; Bromocriptine; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Metoclopramide; Monitoring, Physiologic; Neurosecretory Systems; Prolactin; Receptors, Dopamine; Schizophrenia; Selegiline; Time Factors | 1985 |
Parathyroid hormone and calcitonin secretion in man: effect of dopamine agonists and antagonists.
Topics: Adult; Bromocriptine; Calcitonin; Chlorpromazine; Dopamine; Dopamine Antagonists; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parathyroid Hormone; Prolactin | 1986 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine | 1985 |
Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
[Dopamine agonists in the therapy of parkinson syndrome].
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Bromocriptine; Corpus Striatum; Dopamine; Humans; Levodopa; Lisuride; Neural Pathways; Parkinson Disease; Piribedil; Receptors, Dopamine; Substantia Nigra | 1985 |
Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1985 |
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1985 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
[Clinical significance of long-term treatment of L-dopa with bromocriptine in parkinsonian patients who showed declining efficacy during L-dopa therapy].
Topics: Adult; Aged; Bromocriptine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
[Hyperprolactinemia and ovulatory dysfunction].
Topics: Adult; Anovulation; Bromocriptine; Female; Humans; Levodopa; Pituitary Neoplasms; Prolactin | 1985 |
The role of dopamine in the formation of gastric ulcers in rats.
Topics: Animals; Apomorphine; Bromocriptine; Domperidone; Dopamine; Female; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulpiride | 1985 |
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1985 |
Combined bromocriptine-levodopa therapy early in Parkinson's disease.
Topics: Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
The treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1985 |
Pain in Parkinson's disease.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease | 1985 |
Controversies in the treatment of Parkinson's disease.
Topics: Bromocriptine; Humans; Levodopa; Movement Disorders; Parkinson Disease; Time Factors | 1985 |
[Oral lisuride in Parkinson's disease].
Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |
Treatment of parkinsonism with bromocriptine.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease | 1974 |
Original articles.
Topics: Adenoma, Chromophobe; Adolescent; Adult; Aged; Bromocriptine; Female; Humans; Hypoglycemia; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay | 1974 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
Topics: Aged; Blood Pressure; Bromocriptine; Drug Tolerance; Ergolines; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1980 |
Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro.
Topics: Animals; Bromocriptine; Bucladesine; Calcium; Dopamine; Haloperidol; Hypothalamus; In Vitro Techniques; Levodopa; Male; Neurotransmitter Agents; Potassium; Rats; Somatostatin; Thyrotropin-Releasing Hormone; Veratridine | 1980 |
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia.
Topics: Bromocriptine; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
Hepatic encephalopathy.
Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents | 1981 |
Bromocriptine for levodopa-induced end-of-dose dystonia.
Topics: Aged; Bromocriptine; Dystonia; Female; Humans; Levodopa; Parkinson Disease | 1981 |
The functional role of the noradrenergic neurons in the thermoregulatory circuits in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Biogenic Amines; Body Temperature Regulation; Brain; Bromocriptine; Female; Hydroxydopamines; Kinetics; Levodopa; Male; Mice; Mice, Inbred Strains; Neurons; Norepinephrine; Piribedil | 1981 |
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications | 1981 |
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay | 1982 |
[Drug therapy of parkinsonism].
Topics: Amantadine; Bromocriptine; Dopamine Antagonists; Humans; Levodopa; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease | 1982 |
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cells, Cultured; Dopamine; Endorphins; Female; Growth Hormone; Haloperidol; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin-Releasing Hormone | 1984 |
Treatments for neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male | 1984 |
[Hepatic coma. Therapeutic aspects].
Topics: Amino Acids; Bromocriptine; Electrolytes; Furosemide; Glucose; Hepatic Encephalopathy; Histamine H2 Antagonists; Humans; Infusions, Parenteral; Levodopa; Nitrogen; Spironolactone; Vitamin B Complex | 1984 |
Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease | 1982 |
[Therapeutic concept in Parkinson disease].
Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor | 1983 |
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease | 1983 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Dopamine agonists in the treatment of Parkinson's disease.
Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors | 1983 |
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
Topics: Apomorphine; Brain; Bromocriptine; Humans; Levodopa; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Opioid; Thyrotropin-Releasing Hormone | 1983 |
Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Levodopa; Male; Muridae; Receptors, Dopamine; Synaptic Transmission | 1983 |
Comparison of single and combined tests for the evaluation of plasma growth hormone secretion in normal short children.
Topics: Adolescent; Body Height; Bromocriptine; Child; False Negative Reactions; Growth Hormone; Humans; Hypoglycemia; Insulin; Levodopa; Physical Exertion; Propranolol | 1984 |
Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
Topics: Adenoma; Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Pituitary Gland; Pituitary Neoplasms; Prolactin; Radiography; Syndrome | 1983 |
Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Topics: Age Determination by Skeleton; Bromocriptine; Child; Child, Preschool; Estradiol; Female; Follicle Stimulating Hormone; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Male; Somatomedins; Testosterone; Thyrotropin; Thyroxine | 1984 |
Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
Topics: Benzamides; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Phenethylamines; Selegiline; Tiapamil Hydrochloride | 1984 |
Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteers.
Topics: Apomorphine; Bromocriptine; Dopamine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Levodopa; Phenethylamines; Receptors, Dopamine; Selegiline; Synapses | 1983 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl | 1984 |
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1984 |
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hydroxydopamines; Levodopa; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Receptors, Dopamine; Sex Factors | 1984 |
[Attempted direct etiological treatment of Huntington's chorea. Case reports].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disease; Levodopa; Middle Aged; Piperazines; Piribedil | 1980 |
[Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
Topics: Adolescent; Adult; Arginine; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Receptors, Dopamine; Stimulation, Chemical; Time Factors | 1981 |
Effect of various neuroactive drugs on bromocriptine concentration in the striatum of rats.
Topics: Animals; Bromocriptine; Central Nervous System Agents; Corpus Striatum; Levodopa; Naloxone; Nervous System; Rats | 1984 |
The drug treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease | 1984 |
Bromocriptine in the management of end of dose deterioration in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease | 1984 |
Severity of Parkinson's disease and the dosage of bromocriptine.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies | 1984 |
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine | 1983 |
Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
Topics: Benserazide; Bromocriptine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sexual Dysfunction, Physiological | 1983 |
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
Bromocriptine and lisuride in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1984 |
Clinical administration of parlodel in low doses.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1984 |
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptine.
Topics: Aged; Bromocriptine; Drug Evaluation; Humans; Levodopa; Middle Aged; Parkinson Disease; Retrospective Studies; Time Factors | 1984 |
Diagnosis and management of Parkinson's disease.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor | 1984 |
Long-term efficacy of bromocriptine in Parkinson disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome | 1980 |
Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Levodopa; Metoclopramide; Microsurgery; Pituitary Gland; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1980 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
The use of bromocriptine for testing central dopaminergic reactivity.
Topics: Blood Pressure; Brain; Bromocriptine; Drug Resistance; Humans; Levodopa; Movement Disorders; Parkinson Disease; Receptors, Dopamine; Renin | 1980 |
Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Bromocriptine; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1981 |
Thyrotropin-releasing hormone, chlorpromazine and L-dopa or bromocriptin tests in Cushing's syndrome due to adrenal hyperplasia and adrenal adenoma.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Bromocriptine; Chlorpromazine; Cushing Syndrome; Female; Humans; Hyperplasia; Levodopa; Prolactin; Thyrotropin-Releasing Hormone | 1981 |
The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Topics: Animals; Apomorphine; Bromocriptine; Butyrophenones; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Humans; Levodopa; Male; Muridae; Receptors, Dopamine; Spiperone; Stereotyped Behavior | 1982 |
Bromocriptine and lisuride in Parkinson disease.
Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1983 |
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1983 |
[Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
Topics: Bromocriptine; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1983 |
Recent advances in the treatment of Parkinson's disease.
Topics: Brain; Bromocriptine; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Levodopa; Mental Disorders; Parkinson Disease; Receptors, Dopamine | 1980 |
Differential effects of dopamine agonists in mature and immature rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Animals, Newborn; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Humans; Levodopa; Male; Motor Activity; Rats; Scopolamine; Stereotyped Behavior; Sympathomimetics | 1981 |
[Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
Topics: Adult; Aged; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1982 |
[Idiopathic edema].
Topics: Adult; Bromocriptine; Capillary Permeability; Edema; Female; Humans; Levodopa; Male | 1982 |
Hyperprolactinemia and sexual disorders in men.
Topics: Bromocriptine; Drive; Ejaculation; Erectile Dysfunction; Humans; Levodopa; Libido; Male; Prolactin; Sex Education; Testosterone | 1982 |
Initial treatment of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis | 1982 |
Behavioral alterations and the therapy of parkinsonism.
Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced | 1982 |
Bromocriptine combined with levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease | 1982 |
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
Topics: Aged; Bromocriptine; Carbidopa; Dreams; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1982 |
Prolactin-secreting pituitary adenoma: occurrence following prenatal exposure to diethylstilbestrol.
Topics: Adenoma; Adolescent; Bromocriptine; Chlorpromazine; Diethylstilbestrol; Female; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Prolactin | 1982 |
Bilateral vocal cord paralysis in Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tracheotomy; Vocal Cord Paralysis | 1981 |
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
Method of addition of bromocriptine to the drug regime of patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benzimidazoles; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines | 1981 |
Parkinson's disease: new treatments.
Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus | 1981 |
Bromocriptine and its use in Parkinsonism.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease | 1981 |
Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
Topics: Animals; Apomorphine; Bromocriptine; Levodopa; Male; Metoclopramide; Prolactin; Rats; Serotonin | 1981 |
Treatment of Parkinson's disease: problems with a progressing disease.
Topics: Bromocriptine; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Prognosis; Receptors, Dopamine | 1981 |
Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
Topics: Acromegaly; Adenoma; Adult; Apomorphine; Breast Neoplasms; Bromocriptine; Cells, Cultured; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sympathomimetics | 1981 |
[Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases | 1981 |
A perplexing case of juvenile extrapyramidal disease.
Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Bromocriptine; Electroencephalography; Female; Globus Pallidus; Humans; Levodopa; Parkinson Disease, Secondary; Tomography, X-Ray Computed | 1981 |
"Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic | 1981 |
Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
[Crises in the course of Parkinson's disease].
Topics: Aged; Amantadine; Bromocriptine; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders | 1980 |
Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
Topics: Adult; Bromocriptine; Dopamine; Drug Interactions; Female; Humans; Levodopa; Luteinizing Hormone; Metergoline; Methysergide; Prolactin; Receptors, Dopamine; Serotonin; Serotonin Antagonists | 1980 |
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
Further experiences with low doses of bromocriptine in Parkinson's disease.
Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease | 1980 |
Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
The role of bromocriptine in the treatment of Parkinson's disease.
Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
A comparative study of bromocriptine and levodopa in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1980 |
The role of D-1 and D-2 receptors.
Topics: Adenylyl Cyclases; Bromocriptine; Growth Hormone; Humans; Levodopa; Lisuride; Metoclopramide; Parkinson Disease; Pimozide; Prolactin; Receptors, Dopamine | 1980 |
Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma.
Topics: Adolescent; Adult; Bromocriptine; Calcitonin; Carcinoma; Female; Humans; Kinetics; Levodopa; Male; Middle Aged; Pentagastrin; Thyroid Neoplasms | 1980 |
[Current treatment of Parkinsonian syndrome].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease, Secondary | 1980 |
Lisuride in the treatment of Parkinsonism.
Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1980 |
Treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline | 1995 |
Parkinsonian medication one hour before meals improves symptomatic swallowing: a case study.
Topics: Administration, Oral; Aged; Benserazide; Bromocriptine; Deglutition; Deglutition Disorders; Drug Administration Schedule; Eating; Humans; Levodopa; Male; Parkinson Disease | 1995 |
Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Blood Platelets; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Selegiline; Serotonin; Treatment Outcome | 1995 |
Medullary thyroid carcinoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Bromocriptine; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pheochromocytoma; Recurrence; Survival Rate; Thyroid Neoplasms; Thyroidectomy | 1994 |
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline | 1994 |
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating | 1995 |
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
Topics: Animals; Bromocriptine; Carbidopa; Corpus Striatum; Desipramine; Dopamine; Free Radical Scavengers; Hydroxyl Radical; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine | 1994 |
Seven-year follow-up study of bromocriptine therapy for Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Neurons; Parkinson Disease; Substantia Nigra | 1994 |
Day-night variation of urine volume in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine | 1994 |
[Bromocriptine-induced pleuropneumopathy].
Topics: Benserazide; Biperiden; Bromocriptine; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis; Radiography; Selegiline; Time Factors | 1994 |
Management of neuroleptic malignant syndrome--a series of eight cases.
Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome | 1993 |
[Diagnosis and treatment of Parkinson's disease in the elderly].
Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride | 1993 |
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1994 |
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception | 1993 |
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication.
Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis | 1993 |
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM | 1993 |
Combination therapy for PD.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Randomized Controlled Trials as Topic | 1993 |
Combination therapy for PD.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 1993 |
Event-related potentials in Parkinson's disease: a 12-month follow-up study.
Topics: Adult; Aged; Bromocriptine; Cognition; Drug Therapy, Combination; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies | 1993 |
Parkinson's disease study.
Topics: Benserazide; Bias; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1993 |
Amantadine withdrawal and neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1993 |
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Pyridoxal Phosphate; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors | 1993 |
Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.
Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Dialysis; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar | 1993 |
Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors.
Topics: Adenylate Cyclase Toxin; Animals; Benserazide; Bromocriptine; Calcium; Carbidopa; Carrier Proteins; Cell Line; Cyclic AMP; Dopamine; Kidney Tubules, Proximal; Kinetics; Levodopa; Opossums; Parathyroid Hormone; Pertussis Toxin; Phosphates; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters; Virulence Factors, Bordetella | 1995 |
Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Base Sequence; Behavior, Animal; Bromocriptine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine; Dopamine Agonists; Levodopa; Male; Molecular Sequence Data; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Transcription Factor AP-1 | 1996 |
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Dominance, Cerebral; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Thalamic Nuclei; Treatment Outcome | 1996 |
Levodopa induces AP-1 and CREB DNA-binding activities in the rat striatum.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; CREB-Binding Protein; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gene Expression; Levodopa; Male; Nuclear Proteins; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Trans-Activators; Transcription Factor AP-1; Transcription Factors | 1995 |
Plasma levels of the beta-carbolines harman and norharman in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbolines; Female; Humans; Levodopa; Male; Middle Aged; Mitochondria; Parkinson Disease; Selegiline | 1995 |
Effects of bromocriptine and/or L-DOPA on neurons in substantia nigra of MPTP-treated C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Cell Count; Levodopa; Mice; Mice, Inbred C57BL; Substantia Nigra | 1996 |
Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Encephalitis; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D2; Stereotyped Behavior; Tomography, X-Ray Computed; Trihexyphenidyl | 1996 |
[Malignant-like neuroleptic syndrome: a sign to call attention to].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease | 1995 |
Drug-induced hyperthermia in a patient with persistent vegetative state. Case report and review of the literature.
Topics: Adult; Body Temperature; Bromocriptine; Fever; Follow-Up Studies; Humans; Levodopa; Male; Time Factors | 1995 |
Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Azepines; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hypnotics and Sedatives; Injections, Subcutaneous; Levodopa; Macaca fascicularis; Male; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor | 1997 |
Analyzer workshop on the treatment of Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Bromocriptine; Cerebrovascular Disorders; Computer Simulation; Diagnosis, Differential; Forecasting; Humans; Levodopa; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tablets | 1997 |
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor | 1997 |
Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Topics: Animals; Bromocriptine; Carbidopa; Catalepsy; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Motor Activity | 1997 |
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Receptors, Dopamine D2 | 1998 |
Monitoring randomised controlled trials. Parkinson's disease trial illustrates the dangers of stopping early.
Topics: Antiparkinson Agents; Bromocriptine; Decision Making; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline | 1998 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
Magnetic resonance imaging and 11C-N-methylspiperone/positron emission tomography studies in a patient with the interval form of carbon monoxide poisoning.
Topics: Basal Ganglia; Bromocriptine; Carbon Monoxide Poisoning; Carbon Radioisotopes; Caudate Nucleus; Cerebral Hemorrhage; Combined Modality Therapy; Convalescence; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Globus Pallidus; Humans; Hyperbaric Oxygenation; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nerve Tissue Proteins; Parkinson Disease, Secondary; Psychomotor Performance; Putamen; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1998 |
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Topics: Animals; Autoradiography; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Enkephalins; In Situ Hybridization; Levodopa; Lisuride; Male; Mazindol; Medial Forebrain Bundle; Neostriatum; Oligonucleotide Probes; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Radioligand Assay; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1999 |
Ropinirole: new preparation. Wait for more convincing data.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; France; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Time Factors; Treatment Outcome | 1998 |
Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
Topics: Adult; Antiparkinson Agents; Brain Edema; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methanol; Parkinson Disease, Secondary; Putamen; Tomography, X-Ray Computed | 1999 |
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 1999 |
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors | 1999 |
Influence of dopaminergic anti-Parkinsonian agents on inflammatory reactions in rats.
Topics: Animals; Antiparkinson Agents; Arthritis, Experimental; Benserazide; Bromocriptine; Carrageenan; Dopamine Agents; Edema; Evans Blue; Female; Inflammation; Levodopa; Rats; Rats, Wistar | 2000 |
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2000 |
Influence of dopamine energic pharmacology drugs on secretion of the adrenocorticotropic hormone from the hypophysis.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Carbidopa; Dopamine; Dopamine Agents; Drug Therapy, Combination; Levodopa; Male; Pituitary Gland; Rats; Rats, Wistar | 2000 |
Effects of ropinirole on motor behavior in MPTP-treated common marmosets.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Agonists; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2001 |
Pergolide and Parkinson's disease: new preparation. No clear benefit.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome | 2000 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2001 |
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.
Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Enkephalins; Female; Gene Expression Regulation; Immunohistochemistry; Levodopa; Neostriatum; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympatholytics | 2001 |
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins | 2002 |
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Dyskinesia, Drug-Induced; Female; Gait; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Sympatholytics | 2002 |
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Electrodes, Implanted; Female; Globus Pallidus; Levodopa; Neurons; Organic Chemicals; Parkinsonian Disorders | 2002 |
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Male; Mazindol; Neostriatum; Neural Pathways; Neuropeptides; Parkinsonian Disorders; Protein Precursors; Receptors, Purinergic P1; RNA, Messenger; Tachykinins | 2002 |
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease | 2003 |
Levodopa and bromocriptine in hypoxic brain injury.
Topics: Adult; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Radiography; Tomography, Emission-Computed, Single-Photon | 2002 |
The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
Topics: Adult; Aged; Antiparkinson Agents; British Columbia; Bromocriptine; Data Interpretation, Statistical; Databases, Factual; Drug Prescriptions; Drug Utilization; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors | 2003 |
[Sexual delinquency and Parkinson's disease].
Topics: Antiparkinson Agents; Awareness; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exhibitionism; Expert Testimony; Humans; Impulsive Behavior; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pedophilia; Sex Offenses | 2003 |
The use of dopamine enhancing medications with children in low response states following brain injury.
Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness | 2003 |
[Therapy for patients with early-stage Parkinson's disease].
Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl | 2003 |
[Ludopathy induced by levodopa associated with bromocriptin].
Topics: Bromocriptine; Dopamine Agents; Drug Interactions; Female; Gambling; Humans; Levodopa; Middle Aged | 2003 |
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Dementia; Disease Progression; Dose-Response Relationship, Drug; Employment; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Mortality; Movement Disorders; Multicenter Studies as Topic; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Time Factors | 2005 |
Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.
Topics: Bromocriptine; Cross-Sectional Studies; Disease Progression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2005 |
Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Behavior, Animal; Blotting, Western; Brain Chemistry; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Hindlimb Suspension; Immobility Response, Tonic; Immunohistochemistry; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Nerve Tissue Proteins; Selegiline; Time Factors; Tyrosine 3-Monooxygenase | 2005 |
A proposed mechanism for diurnal/nocturnal bruxism: hypersensitivity of presynaptic dopamine receptors in the frontal lobe.
Topics: Aged; Bromocriptine; Bruxism; Dopamine Agents; Female; Frontal Lobe; Humans; Levodopa; Male; Metoclopramide; Receptors, Dopamine; Sleep Bruxism | 2005 |
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2005 |
Bromocriptine in traumatic brain injury.
Topics: Brain Injuries; Bromocriptine; Cognition; Dopamine Agonists; Head Injuries, Closed; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance | 2006 |
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis | 2006 |
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome | 2006 |
Changes in gait and symptoms after bilateral pallidotomy: a client with Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Disease Progression; Female; Gait; Globus Pallidus; Humans; Levodopa; Middle Aged; Pallidotomy; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
Topics: Analysis of Variance; Animals; Brain Injuries; Bromocriptine; Cell Count; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Immunohistochemistry; Levodopa; Lipopolysaccharides; Movement Disorders; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
[Juvenile Parkinson's disease and recurring prematurity. Case report].
Topics: Adult; Antiparkinson Agents; Bromocriptine; Female; Humans; Infant, Newborn; Infant, Premature; Levodopa; Obstetric Labor, Premature; Parkinsonian Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2007 |
Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine.
Topics: Adolescent; Antiparkinson Agents; Bromocriptine; Catechols; Drug Therapy, Combination; Epilepsy; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pregnancy; Prenatal Exposure Delayed Effects | 2007 |
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.
Topics: Bromocriptine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Indoles; Levodopa; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Randomized Controlled Trials as Topic; Time; Treatment Outcome | 2009 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
Topics: Animals; Binding, Competitive; Brain; Brain Chemistry; Bromocriptine; Cannabinoid Receptor Modulators; CHO Cells; Cricetinae; Cricetulus; Drug Administration Schedule; Female; Levodopa; Positron-Emission Tomography; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Up-Regulation | 2010 |
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Oxidopamine; Parkinsonian Disorders; Piribedil; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation; Time Factors | 2010 |
[General anaesthesia for neurological diseases].
Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Brain; Bromocriptine; Dopamine Agonists; Humans; Intubation; Levodopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Nervous System Diseases; Neurodegenerative Diseases; Neurosurgery; Parkinson Disease; Piperidines; Premedication; Preoperative Care; Propofol; Remifentanil; Selegiline; Stereotaxic Techniques; Syndrome | 2010 |
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; New South Wales; Parkinson Disease; Survival Analysis | 2011 |
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies | 2011 |
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase | 2013 |
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture | 2013 |
Alteration in the expression of exon IIC transcripts of brain-derived neurotrophic factor gene by simvastatin [correction of simvastain] in chronic mild stress in mice: a possible link with dopaminergic pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Bromocriptine; Chronic Disease; Dopamine; Dopamine Agents; Eating; Exons; Haloperidol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Levodopa; Lipid Metabolism; Male; Mice; Signal Transduction; Simvastatin; Stress, Psychological; Sucrose; Transcription, Genetic | 2014 |
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.
Topics: Animals; Antiparkinson Agents; Biosensing Techniques; Bromocriptine; Catecholamines; Dopamine Agonists; Dopaminergic Neurons; Equipment Design; Levodopa; Mice; Molecular Imaging; Nanotechnology; Neuroimaging; Parkinson Disease; Precision Medicine; Substantia Nigra | 2017 |
Dopamine D
Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Diabetes Mellitus, Type 2; Dopamine; Dopamine Agonists; Female; Glucose; Insulin; Insulin-Secreting Cells; Levodopa; Mice; Mice, Inbred C57BL; Obesity; Receptors, Dopamine D2; Sulpiride; Weight Gain | 2020 |
D
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain; Bromocriptine; Chlorocebus aethiops; Disease Models, Animal; Dopamine Agonists; Levodopa; Male; Motor Activity; Parkinsonian Disorders; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |